☰

Nina Bhardwaj - Publications

Affiliations: 
Basic Medical Science New York University, New York, NY, United States 
Area:
Cell Biology, Microbiology Biology, Molecular Biology
Tree Info Similar researchers PubMed Report error

330 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Anker J, Pal SK, Kim-Schulze S, Wang H, Halperin R, Uzilov A, Imai N, Eikawa S, Saito T, Sebra R, Hahn NM, Patel M, Qi J, Xie H, Bhardwaj N, et al. Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer. Journal For Immunotherapy of Cancer. 11. PMID 37607770 DOI: 10.1136/jitc-2023-007613  0.356
2023 Brown M, Tran MA, Bhardwaj N. Cancer immunity derailed: PGE misconducts cDC1s. Immunity. 56: 1165-1167. PMID 37315532 DOI: 10.1016/j.immuni.2023.05.015  0.354
2022 Mestrallet G, Sone K, Bhardwaj N. Strategies to overcome DC dysregulation in the tumor microenvironment. Frontiers in Immunology. 13: 980709. PMID 36275666 DOI: 10.3389/fimmu.2022.980709  0.413
2022 Salomé B, Sfakianos JP, Ranti D, Daza J, Bieber C, Charap A, Hammer C, Banchereau R, Farkas AM, Ruan DF, Izadmehr S, Geanon D, Kelly G, de Real RM, Lee B, ... ... Bhardwaj N, et al. NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer. Cancer Cell. 40: 1027-1043.e9. PMID 36099881 DOI: 10.1016/j.ccell.2022.08.005  0.342
2022 Gigoux M, Holmström MO, Zappasodi R, Park JJ, Pourpe S, Bozkus CC, Mangarin LMB, Redmond D, Verma S, Schad S, George MM, Venkatesh D, Ghosh A, Hoyos D, Molvi Z, ... ... Bhardwaj N, et al. Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine. Science Translational Medicine. 14: eaba4380. PMID 35704596 DOI: 10.1126/scitranslmed.aba4380  0.346
2021 Cimen Bozkus C, Blazquez AB, Enokida T, Bhardwaj N. A T-cell-based immunogenicity protocol for evaluating human antigen-specific responses. Star Protocols. 2: 100758. PMID 34458873 DOI: 10.1016/j.xpro.2021.100758  0.307
2021 Weingarten-Gabbay S, Klaeger S, Sarkizova S, Pearlman LR, Chen DY, Gallagher KME, Bauer MR, Taylor HB, Dunn WA, Tarr C, Sidney J, Rachimi S, Conway HL, Katsis K, Wang Y, ... ... Bhardwaj N, et al. Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs. Cell. PMID 34171305 DOI: 10.1016/j.cell.2021.05.046  0.32
2021 Li MO, Wolf N, Raulet DH, Akkari L, Pittet MJ, Rodriguez PC, Kaplan RN, Munitz A, Zhang Z, Cheng S, Bhardwaj N. Innate immune cells in the tumor microenvironment. Cancer Cell. 39: 725-729. PMID 34129817 DOI: 10.1016/j.ccell.2021.05.016  0.321
2020 Bhardwaj N, Friedlander PA, Pavlick AC, Ernstoff MS, Gastman BR, Hanks BA, Curti BD, Albertini MR, Luke JJ, Blazquez AB, Balan S, Bedognetti D, Beechem JM, Crocker AS, D'Amico L, et al. Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets. Nature Cancer. 1: 1204-1217. PMID 35121932 DOI: 10.1038/s43018-020-00143-y  0.456
2020 Sfakianos JP, Salome B, Daza J, Farkas A, Bhardwaj N, Horowitz A. Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer. Urologic Oncology. PMID 33262028 DOI: 10.1016/j.urolonc.2020.09.031  0.328
2020 Balan S, Radford KJ, Bhardwaj N. Unexplored horizons of cDC1 in immunity and tolerance. Advances in Immunology. 148: 49-91. PMID 33190733 DOI: 10.1016/bs.ai.2020.10.002  0.414
2020 Baharom F, Ramirez-Valdez RA, Tobin KKS, Yamane H, Dutertre CA, Khalilnezhad A, Reynoso GV, Coble VL, Lynn GM, Mulè MP, Martins AJ, Finnigan JP, Zhang XM, Hamerman JA, Bhardwaj N, et al. Intravenous nanoparticle vaccination generates stem-like TCF1 neoantigen-specific CD8 T cells. Nature Immunology. PMID 33139915 DOI: 10.1038/s41590-020-00810-3  0.377
2020 Ott PA, Hu-Lieskovan S, Chmielowski B, Govindan R, Naing A, Bhardwaj N, Margolin K, Awad MM, Hellmann MD, Lin JJ, Friedlander T, Bushway ME, Balogh KN, Sciuto TE, Kohler V, et al. A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer. Cell. 183: 347-362.e24. PMID 33064988 DOI: 10.1016/j.cell.2020.08.053  0.392
2020 Bhardwaj N, Farkas AM, Gul Z, Sfakianos JP. Harnessing Natural Killer Cell Function for Genitourinary Cancers. The Urologic Clinics of North America. 47: 433-442. PMID 33008494 DOI: 10.1016/J.Ucl.2020.07.002  0.429
2020 Attalla K, Farkas AM, Anastos H, Audenet F, Galsky MD, Bhardwaj N, Sfakianos JP. TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancer. Urologic Oncology. PMID 32665122 DOI: 10.1016/J.Urolonc.2020.06.007  0.44
2020 Balan S, Bhardwaj N. Cross-Presentation of Tumor Antigens Is Ruled by Synaptic Transfer of Vesicles among Dendritic Cell Subsets. Cancer Cell. 37: 751-753. PMID 32516584 DOI: 10.1016/J.Ccell.2020.05.013  0.441
2020 Maier B, Leader AM, Chen ST, Tung N, Chang C, LeBerichel J, Chudnovskiy A, Maskey S, Walker L, Finnigan JP, Kirkling ME, Reizis B, Ghosh S, D'Amore NR, Bhardwaj N, et al. Author Correction: A conserved dendritic-cell regulatory program limits antitumour immunity. Nature. PMID 32499658 DOI: 10.1038/S41586-020-2326-5  0.356
2020 Maier B, Leader AM, Chen ST, Tung N, Chang C, LeBerichel J, Chudnovskiy A, Maskey S, Walker L, Finnigan JP, Kirkling ME, Reizis B, Ghosh S, D'Amore NR, Bhardwaj N, et al. A conserved dendritic-cell regulatory program limits antitumour immunity. Nature. 580: 257-262. PMID 32269339 DOI: 10.1038/S41586-020-2134-Y  0.497
2020 Roudko V, Greenbaum B, Bhardwaj N. Computational Prediction and Validation of Tumor-Associated Neoantigens. Frontiers in Immunology. 11: 27. PMID 32117226 DOI: 10.3389/Fimmu.2020.00027  0.476
2020 Wang L, Sebra RP, Sfakianos JP, Allette K, Wang W, Yoo S, Bhardwaj N, Schadt EE, Yao X, Galsky MD, Zhu J. A reference profile-free deconvolution method to infer cancer cell-intrinsic subtypes and tumor-type-specific stromal profiles. Genome Medicine. 12: 24. PMID 32111252 DOI: 10.1186/S13073-020-0720-0  0.339
2020 Kodysh J, Marron T, Rubinsteyn A, O'Donnell T, Finnigan J, Blazquez A, Saxena M, Meseck M, Friedlander P, Bhardwaj N. Abstract CT173: PGV-001: A phase I trial of a multipeptide personalized neoantigen vaccine in the adjuvant setting Tumor Biology. DOI: 10.1158/1538-7445.Am2020-Ct173  0.313
2019 Perumal D, Imai N, Laganà A, Finnigan J, Melnekoff D, Leshchenko VV, Solovyov A, Madduri D, Chari A, Cho HJ, Dudley JT, Brody JD, Jagannath S, Greenbaum B, Gnjatic S, ... Bhardwaj N, et al. Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31857430 DOI: 10.1158/1078-0432.Ccr-19-2309  0.458
2019 Balan S, Saxena M, Bhardwaj N. Dendritic cell subsets and locations. International Review of Cell and Molecular Biology. 348: 1-68. PMID 31810551 DOI: 10.1016/Bs.Ircmb.2019.07.004  0.488
2019 Pavlick A, Blazquez AB, Meseck M, Lattanzi M, Ott PA, Marron TU, Holman RM, Mandeli J, Salazar AM, McClain CB, Gimenez G, Balan S, Gnjatic S, Sabado RL, Bhardwaj N. Combined vaccination with NY-ESO-1 protein, poly-ICLC, and montanide improves humoral and cellular immune responses in high-risk melanoma patients. Cancer Immunology Research. PMID 31699709 DOI: 10.1158/2326-6066.Cir-19-0545  0.777
2019 Wang L, Gong Y, Saci A, Szabo PM, Martini A, Necchi A, Siefker-Radtke A, Pal S, Plimack ER, Sfakianos JP, Bhardwaj N, Horowitz A, Farkas AM, Mulholland D, Fischer BS, et al. Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial Cancer. European Urology. PMID 31272788 DOI: 10.1016/J.Eururo.2019.06.025  0.33
2019 Cimen Bozkus C, Roudko V, Finnigan JP, Mascarenhas J, Hoffman R, Iancu-Rubin C, Bhardwaj N. Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T Cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms. Cancer Discovery. PMID 31266769 DOI: 10.1158/2159-8290.Cd-18-1356  0.452
2019 Saxena M, Sabado RL, La Mar M, Mohri H, Salazar AM, Dong H, Correa Da Rosa J, Markowitz M, Bhardwaj N, Miller E. Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial. Frontiers in Immunology. 10: 725. PMID 31024557 DOI: 10.3389/Fimmu.2019.00725  0.743
2019 Blazquez A, Rubinsteyn A, Kodysh J, Finnigan JP, Marron TU, Meseck M, O'Donnell T, Hammerbacher J, Donovan MJ, Mahajan M, Miles BA, Irie H, Tiersten A, Tewari A, Parekh SS, ... ... Bhardwaj N, et al. A phase I study of the safety and immunogenicity of a multi-peptide personalized genomic vaccine in the adjuvant treatment of solid tumors and hematological malignancies. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E14307  0.369
2019 Pavlick AC, Blazquez A, Meseck M, Donovan MJ, Castillo-Martin M, Htwe Thin T, Sabado R, Mandeli JP, Gnjatic S, Friedlander PA, Bhardwaj N. A phase II open labeled, randomized study of poly-ICLC matured dendritic cells for NY-ESO-1 and Mean-A peptide vaccination compared to Montanide, in melanoma patients in complete clinical remission. Journal of Clinical Oncology. 37: 9538-9538. DOI: 10.1200/Jco.2019.37.15_Suppl.9538  0.794
2019 Luksza M, Solovyov A, Vabret N, Balachandran V, Riaz N, Makarov V, Hellmann MD, Snyder A, Funt S, Remark R, Merad M, Gnjatic S, Bajorin DF, Rosenberg J, Leach S, ... ... Bhardwaj N, et al. Abstract IA31: Measuring the emergence of non-self in tumors Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-Ia31  0.37
2019 Rizvi N, Tang P, Bhardwaj N, Chan TA, Weber JS, Vickers M, Pintova S, Hirte H, Segal NH, Dhani N, Cho D, Chia S, Burns C, Tu D, Pearce L, et al. Abstract B207: Nivolumab +/- Ipilimumab in patients with hypermutated cancers detected in blood: NIMBLE Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B207  0.333
2019 Farkas AM, Audenet F, Anastos H, Galsky M, Sfakianos JP, Bhardwaj N. Abstract B157: Modulation of natural killer cell dysfunction in human bladder cancer Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B157  0.447
2019 Finnigan JP, Ishizuka AS, Lynn GM, Rubinsteyn A, Seder RA, Bhardwaj N. Abstract B108: Molecular and cellular properties of neoantigen-specific CD8+ T-cells on interaction with B16F10 melanoma in situ Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B108  0.505
2019 Kodysh J, O'Donnell T, Blazquez AB, Finnigan J, Bhardwaj N, Rubinsteyn A. Abstract B080: Improved neoantigen vaccine selection by combining prediction of pMHC presentation and T-cell epitopes Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B080  0.475
2019 Bozkus CC, Roudko V, Finnigan JP, Mascarenhas J, Hoffman R, Iancu-Rubin C, Bhardwaj N. Abstract B072: Immune checkpoint blockade enhances mutated calreticulin-induced T-cell immunity in myeloproliferative neoplasms Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B072  0.443
2019 O’Donnell TJ, Shan M, Merritt E, Gugel EG, Blasquez AB, Meseck M, Friedlander PA, Rubinsteyn A, Horowitz A, Bhardwaj N, Laserson U. Abstract B032: PhIP-seq assessment of the serum antibody repertoire before and after immune-related adverse events in four melanoma patients treated with checkpoint blockade immunotherapy Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B032  0.384
2019 Gonzalez-Gugel E, Sadanala KC, Rahman A, Blumberg RS, Horowitz A, Bhardwaj N. Abstract A191: Novel approaches to the study of NK cell exhaustion in humans Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-A191  0.395
2019 Saxena M, Sadanala KC, Muniz-Bongers LR, Bhardwaj N. Abstract A109: Matrix metalloproteinase-2 stimulates Toll-like receptor-2 on melanoma cells to induce immunosuppressive inflammation in the tumor microenvironment Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-A109  0.418
2019 Blazquez AB, Rubinsteyn A, Kodysh J, Finnigan JP, Marron T, Sabado RL, Meseck M, O'Donnell TJ, Hammerbacher J, Donovan M, Holt J, Mahajan M, Mandeli J, Misiukiewicz K, Genden EM, ... ... Bhardwaj N, et al. Abstract A005: A phase I study of the safety and immunogenicity of a multipeptide personalized genomic vaccine in the adjuvant treatment of solid cancers Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-A005  0.756
2019 Sanborn RE, Gabrail NY, Bhardwaj N, Gordon MS, O'Hara M, Khalil D, Hawthorne T, Gedrich R, Vitale L, Rogalski M, Li T, Rawls T, Keler T, Yellin M. Abstract LB-194: First-in-human Phase I study of the CD40 agonist mAb CDX-1140 and in combination with CDX-301 (rhFLT3L) in patients with advanced cancers: Interim results Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-194  0.414
2019 Nair SS, Weil R, Gonzalez-Gugel E, Meseck M, Rubinsteyn A, Kodysh Y, Gupta A, Sadanala K, Schlussel K, Bhatt K, Reddy A, Patel R, Thawte T, Farkas A, Dzedzik S, ... ... Bhardwaj N, et al. Abstract CT096: Phase I study of in situ autologous vaccination for prostate cancer in a neo-adjuvant setting Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Ct096  0.385
2019 Hormigo A, Rubinsteyn A, Kodysh J, Blazquez A, Bhardwaj N. Abstract CT062: A Phase I study of the safety and immunogenicity of personalized mutation-derived tumor vaccine and treatment fields in patients with newly diagnosed glioblastoma Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Ct062  0.434
2019 Sfakianos* J, Farkas A, Daza J, Anastos H, Galsky M, Bhardwaj N. MP57-19 TIM-3 AND TIGIT ARE POTENTIAL IMMUNE CHECKPOINT TARGETS IN PATIENTS WITH BLADDER CANCER Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556617.79234.9F  0.351
2019 Orfanelli T, Roudko V, Bozkus CC, Greenbaum B, Blank S, Bhardwaj N. Shared tumor antigens in uterine cancers with microsatellite instability: Putative targets for immunotherapeutic approaches Gynecologic Oncology. 154: 91. DOI: 10.1016/J.Ygyno.2019.04.214  0.344
2018 Ott PA, Govindan R, Naing A, Friedlander TW, Margolin K, Lin JJ, Bhardwaj N, Hellman MD, Srinivasan L, Greshock J, Moles M, Gaynor RB, Goldstein MJ, Hu-Lieskovan S. A personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 29: viii400. PMID 32137002 DOI: 10.1093/Annonc/Mdy288  0.398
2018 Friedlander P, Wood K, Wassmann K, Christenfeld AM, Bhardwaj N, Oh WK. A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab. Journal For Immunotherapy of Cancer. 6: 90. PMID 30227886 DOI: 10.1186/S40425-018-0408-9  0.324
2018 Wang L, Saci A, Szabo PM, Chasalow SD, Castillo-Martin M, Domingo-Domenech J, Siefker-Radtke A, Sharma P, Sfakianos JP, Gong Y, Dominguez-Andres A, Oh WK, Mulholland D, Azrilevich A, Hu L, ... ... Bhardwaj N, et al. EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer. Nature Communications. 9: 3503. PMID 30158554 DOI: 10.1038/S41467-018-05992-X  0.355
2018 Saxena M, Balan S, Roudko V, Bhardwaj N. Towards superior dendritic-cell vaccines for cancer therapy. Nature Biomedical Engineering. 2: 341-346. PMID 30116654 DOI: 10.1038/S41551-018-0250-X  0.453
2018 Balan S, Arnold-Schrauf C, Abbas A, Couespel N, Savoret J, Imperatore F, Villani AC, Vu Manh TP, Bhardwaj N, Dalod M. Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity. Cell Reports. 24: 1902-1915.e6. PMID 30110645 DOI: 10.1016/J.Celrep.2018.07.033  0.428
2018 Kyi C, Roudko V, Sabado R, Saenger YM, Loging W, Mandeli J, Donovan M, Lehrer D, Posner MR, Misiukiewicz K, Greenbaum B, Salazar AM, Friedlander P, Bhardwaj N. Therapeutic Immune Modulation Against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29950349 DOI: 10.1158/1078-0432.Ccr-17-1866  0.751
2018 Barry KC, Hsu J, Broz ML, Cueto FJ, Binnewies M, Combes AJ, Nelson AE, Loo K, Kumar R, Rosenblum MD, Alvarado MD, Wolf DM, Bogunovic D, Bhardwaj N, Daud AI, et al. A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments. Nature Medicine. PMID 29942093 DOI: 10.1038/S41591-018-0085-8  0.723
2018 Nowatzky J, Manches O, Khan SA, Godefroy E, Bhardwaj N. Modulation of human Th17 cell responses through complement receptor 3 (CD11 b/CD18) ligation on monocyte-derived dendritic cells. Journal of Autoimmunity. PMID 29908907 DOI: 10.1016/J.Jaut.2018.05.005  0.448
2018 Audenet F, Farkas AM, Anastos H, Galsky MD, Bhardwaj N, Sfakianos JP. Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer. World Journal of Urology. PMID 29860605 DOI: 10.1007/S00345-018-2359-7  0.346
2018 Lattanzi M, Han J, Moran U, Utter K, Tchack J, Sabado RL, Berman R, Shapiro R, Huang HH, Osman I, Bhardwaj N, Pavlick AC. Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis. Journal For Immunotherapy of Cancer. 6: 38. PMID 29773080 DOI: 10.1186/S40425-018-0345-7  0.73
2018 Solovyov A, Vabret N, Arora KS, Snyder A, Funt SA, Bajorin DF, Rosenberg JE, Bhardwaj N, Ting DT, Greenbaum BD. Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes. Cell Reports. 23: 512-521. PMID 29642008 DOI: 10.1016/J.Celrep.2018.03.042  0.381
2018 Saxena M, Bhardwaj N. Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment. Trends in Cancer. 4: 119-137. PMID 29458962 DOI: 10.1016/J.Trecan.2017.12.007  0.543
2018 Bhardwaj N. Abstract SY14-02: Personalized therapies: Neoantigen discovery and vaccination Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Sy14-02  0.457
2018 Ott PA, Govindan R, Naing A, Friedlander TW, Margolin K, Lin JJ, Bhardwaj N, Hellmann MD, Srinivasan L, Greshock J, Moles M, Gaynor RB, Goldstein MJ, Hu-Lieskovan S. Abstract CT125: A personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Ct125  0.498
2018 Farkas AM, Audenet F, Anastos H, Oh WK, Galsky MD, Sfakianos JP, Bhardwaj N. Abstract 4745: Tim-3 and TIGIT mark NK and T cells susceptible to effector dysfunction in human bladder cancer Cancer Research. 78: 4745-4745. DOI: 10.1158/1538-7445.Am2018-4745  0.429
2018 Hormigo A, Rubinsteyn A, Kodysh J, Yong R, Hadjipanayis C, Bederson J, Tsankova N, Houldsworth J, Bhardwaj N. ATIM-31. PHASE I STUDY OF TUMOR TREATMENT FIELDS AND A PERSONALIZED MUTATION-DERIVED TUMOR VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA Neuro-Oncology. 20: vi8-vi8. DOI: 10.1093/Neuonc/Noy148.026  0.354
2017 Bhardwaj N. Modulating innate immune mechanisms to improve anti- tumor immunity. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 28: ix26. PMID 32120567 DOI: 10.1093/Annonc/Mdx561  0.387
2017 Rubinsteyn A, Kodysh J, Hodes I, Mondet S, Aksoy BA, Finnigan JP, Bhardwaj N, Hammerbacher J. Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial. Frontiers in Immunology. 8: 1807. PMID 29403468 DOI: 10.3389/Fimmu.2017.01807  0.364
2017 Galsky MD, Wang H, Hahn NM, Twardowski P, Pal SK, Albany C, Fleming MT, Starodub A, Hauke RJ, Yu M, Zhao Q, Sonpavde G, Donovan MJ, Patel VG, Sfakianos JP, ... ... Bhardwaj N, et al. Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes. European Urology. PMID 29248319 DOI: 10.1016/J.Eururo.2017.12.001  0.321
2017 Saxena M, Bhardwaj N. Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines. Current Opinion in Immunology. 47: 35-43. PMID 28732279 DOI: 10.1016/J.Coi.2017.06.003  0.512
2017 Balan S, Finnigan J, Bhardwaj N. Dendritic Cell Strategies for Eliciting Mutation-Derived Tumor Antigen Responses in Patients. Cancer Journal (Sudbury, Mass.). 23: 131-137. PMID 28410301 DOI: 10.1097/Ppo.0000000000000251  0.522
2017 Kyi C, Sabado RL, Saenger YM, Loging W, Donovan MJ, Lehrer D, Mandeli JP, Salazar AM, Friedlander PA, Bhardwaj N. Trials in progress: A phase II study of in situ therapeutic vaccination against refractory solid cancers with intratumoral poly-ICLC. Journal of Clinical Oncology. 35: 166-166. DOI: 10.1200/Jco.2017.35.7_Suppl.166  0.765
2017 Galsky MD, Uzilov AV, McBride RB, Wang H, Patel VG, Sfakianos J, Wang L, Akers N, Iyer G, Solit DB, Saito T, Castillo-Martin M, Hahn NM, Pal SK, Fleming MT, ... ... Bhardwaj N, et al. DNA damage response (DDR) gene mutations (mut), mut load, and sensitivity to chemotherapy plus immune checkpoint blockade in urothelial cancer (UC). Journal of Clinical Oncology. 35: 300-300. DOI: 10.1200/Jco.2017.35.6_Suppl.300  0.33
2017 Kyi C, Sabado RL, Blazquez A, Posner MR, Genden EM, Miles BA, Khorasani H, Dottino PR, Irie H, Port ER, Wolf AS, Cho HJ, Parekh SS, Mandeli J, Galsky M, ... ... Bhardwaj N, et al. A phase I study of the safety and immunogenicity of a multipeptide personalized genomic vaccine in the adjuvant treatment of solid cancers. Journal of Clinical Oncology. 35: TPS3114-TPS3114. DOI: 10.1200/Jco.2017.35.15_Suppl.Tps3114  0.756
2017 Slingluff CL, Dasilva D, Schwarzenberger P, Ricciardi T, Macri MJ, Ryan A, Venhaus RR, Bhardwaj N. Phase 1/2 study of in situ vaccination with tremelimumab + intravenous (IV) durvalumab + poly-ICLC in patients with select relapsed, advanced cancers with measurable, biopsy-accessible tumors. Journal of Clinical Oncology. 35: TPS3106-TPS3106. DOI: 10.1200/Jco.2017.35.15_Suppl.Tps3106  0.425
2017 Bozkus CC, Finnigan JP, Mascarenhas J, Hoffman R, Bhardwaj N, Iancu-Rubin C. Immune Checkpoint Blockade Enhances Mutated Calreticulin-Induced T Cell Immunity in Myeloproliferative Neoplasms Blood. 130: 384-384. DOI: 10.1182/Blood.V130.Suppl_1.384.384  0.441
2017 Sfakianos JP, Farkas AD, Anastos H, Galsky MD, Bhardwaj N. Comprehensive immune profiling of patients with urothelial carcinoma of the bladder identifies a novel immune target Urologic Oncology-Seminars and Original Investigations. 35: 618. DOI: 10.1016/J.Urolonc.2017.06.035  0.362
2016 Sabado RL, Balan S, Bhardwaj N. Dendritic cell-based immunotherapy. Cell Research. PMID 28025976 DOI: 10.1038/Cr.2016.157  0.777
2016 Roberts EW, Broz ML, Binnewies M, Headley MB, Nelson AE, Wolf DM, Kaisho T, Bogunovic D, Bhardwaj N, Krummel MF. Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma. Cancer Cell. PMID 27424807 DOI: 10.1016/J.Ccell.2016.06.003  0.728
2016 Gonzalez-Gugel E, Saxena M, Bhardwaj N. Modulation of innate immunity in the tumor microenvironment. Cancer Immunology, Immunotherapy : Cii. PMID 27344341 DOI: 10.1007/S00262-016-1859-9  0.526
2016 Salmon H, Idoyaga J, Rahman A, Leboeuf M, Remark R, Jordan S, Casanova-Acebes M, Khudoynazarova M, Agudo J, Tung N, Chakarov S, Rivera C, Hogstad B, Bosenberg M, Hashimoto D, ... ... Bhardwaj N, et al. Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition. Immunity. 44: 924-38. PMID 27096321 DOI: 10.1016/J.Immuni.2016.03.012  0.434
2016 O'Brien M, Manches O, Wilen C, Gopal R, Huq R, Wu V, Sunseri N, Bhardwaj N. CD4 Receptor is a Key Determinant of Divergent HIV-1 Sensing by Plasmacytoid Dendritic Cells. Plos Pathogens. 12: e1005553. PMID 27082754 DOI: 10.1371/Journal.Ppat.1005553  0.406
2016 Sabado RL, Meseck M, Bhardwaj N. Dendritic Cell Vaccines. Methods in Molecular Biology (Clifton, N.J.). 1403: 763-77. PMID 27076166 DOI: 10.1007/978-1-4939-3387-7_44  0.769
2016 Romero P, Banchereau J, Bhardwaj N, Cockett M, Disis ML, Dranoff G, Gilboa E, Hammond SA, Hershberg R, Korman AJ, Kvistborg P, Melief C, Mellman I, Palucka AK, Redchenko I, et al. The Human Vaccines Project: A roadmap for cancer vaccine development. Science Translational Medicine. 8: 334ps9. PMID 27075624 DOI: 10.1126/Scitranslmed.Aaf0685  0.419
2016 Kohrt HE, Tumeh PC, Benson D, Bhardwaj N, Brody J, Formenti S, Fox BA, Galon J, June CH, Kalos M, Kirsch I, Kleen T, Kroemer G, Lanier L, Levy R, et al. Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials. Journal For Immunotherapy of Cancer. 4: 15. PMID 26981245 DOI: 10.1186/S40425-016-0118-0  0.348
2016 Hammerich L, Bhardwaj N, Kohrt HE, Brody JD. In situ vaccination for the treatment of cancer. Immunotherapy. PMID 26860335 DOI: 10.2217/Imt.15.120  0.472
2016 Galsky MD, Hahn NM, Albany C, Fleming MT, Starodub A, Twardowski P, Pal SK, Hauke RJ, Sonpavde G, Oh WK, Bhardwaj N, Gnjatic S, Kim-Schulze S, Liu Z. Phase II trial of gemcitabine + cisplatin + ipilimumab in patients with metastatic urothelial cancer. Journal of Clinical Oncology. 34: 357-357. DOI: 10.1200/Jco.2016.34.2_Suppl.357  0.419
2016 Aleynick M, Peng P, Hammerich L, Tanne A, Agudo J, Brown BD, Bhardwaj N, Brody J. Natural pattern-recognition-receptor agonists in prophylactic vaccines for in situ vaccination of lymphoma. Journal of Clinical Oncology. 34: e14516-e14516. DOI: 10.1200/Jco.2016.34.15_Suppl.E14516  0.369
2016 Bhardwaj N, Pavlick AC, Ernstoff MS, Hanks BA, Albertini MR, Luke JJ, Yellin MJ, Keler T, Davis TA, Crocker A, Vitale L, Morishima C, Friedlander PA, Cheever MA, Fling S. A Phase II Randomized Study of CDX-1401, a Dendritic Cell Targeting NY-ESO-1 Vaccine, in Patients with Malignant Melanoma Pre-Treated with Recombinant CDX-301, a Recombinant Human Flt3 Ligand. Journal of Clinical Oncology. 34: 9589-9589. DOI: 10.1200/Jco.2016.34.15_Suppl.9589  0.458
2016 Kyi C, Sabado RL, Saenger YM, Posner MR, Donovan M, Loging W, Sacris E, Mandeli JP, Htwe Thin T, Misiukiewicz K, Maki RG, Salazar AM, Friedlander PA, Bhardwaj N. In situ, therapeutic vaccination against refractory solid cancers with intratumoral Poly-ICLC: A phase I study. Journal of Clinical Oncology. 34: 3086-3086. DOI: 10.1200/Jco.2016.34.15_Suppl.3086  0.752
2016 Lattanzi MW, Han J, Moran U, Utter K, Tchack J, Sabado RL, Bhardwaj N, Osman I, Pavlick AC. Retrospective cohort analysis of adjuvant NY-ESO-1 vaccines in stage III melanoma. Journal of Clinical Oncology. 34: 3084-3084. DOI: 10.1200/Jco.2016.34.15_Suppl.3084  0.735
2016 Althammer S, Steele K, Rebelatto M, Tan TH, Wiestler T, Schmidt G, Higgs B, Li X, Shi L, Jin X, Antal J, Gupta A, Ranade K, Binning G, Bellmunt J, ... ... Bhardwaj N, et al. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts Journal For Immunotherapy of Cancer. 4. DOI: 10.1186/S40425-016-0191-4  0.328
2016 Iancu-Rubin C, Fong H, Mosoyan G, Patel A, Sabado R, Marcia M, Moshier E, Ozbek U, Keyzner A, Bhardwaj N, McNiece IK, Tong J, Hoffman R. Preclinical Development of a Cord Blood (CB)-Derived Hematopoietic Stem Cell (HSC) Product for Allogeneic Transplantation in Patients with Hematological Malignancies Blood. 128: 818-818. DOI: 10.1182/Blood.V128.22.818.818  0.711
2016 Muniz LR, Saxena M, Bhardwaj N. Abstract B169: Matrix metalloproteinase-2 and Toll-like receptors modulating immune responses in the tumor microenvironment Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-B169  0.406
2016 Gonzalez-Gugel E, Ensanyat S, Munk A, Bhardwaj N. Abstract B161: Mechanisms underlying the induction of natural killer cell exhaustion in metastatic melanoma Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-B161  0.441
2016 Saxena M, Muniz LR, Bhardwaj N. Abstract B160: Matrix metalloproteinase-2 modulates inflammation and melanoma progression via TLR2 Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-B160  0.421
2016 Salmon H, Idoyaga J, Rahman A, Palucka AK, Bhardwaj N, Ginhoux F, Merad M. Abstract B058: Expansion and activation of CD103+ DC progenitors at the tumor site promote T cell accumulation in melanoma lesions and transform clinical response to BRAF and PD-L1 blockade Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-B058  0.432
2016 Tanne A, Muniz L, Ting D, Levine A, Bhardwaj N, Greenbaum B. Abstract A077: Unraveling predicted immunomodulatory effects of novel cancer-associated noncoding RNAs Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-A077  0.402
2016 Salmon H, Idoyaga J, Rahman A, Remark R, Gnjatic S, Bhardwaj N, Brody J, Palucka AK, Ginhoux F, Merad M. Abstract B015: Expansion and activation of CD103+dendritic cell progenitors at the tumor site transform tumor response to PD-L1 and BRAF inhibition Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-B015  0.442
2016 Solovyov A, Tanne A, Muniz L, Cocco S, Monasson R, Levine A, Ting DT, Bhardwaj N, Greenbaum B. Abstract A087: Quantifying the landscape of immunostimulatory tumoral RNA Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-A087  0.355
2016 Rubinsteyn A, Hodes I, O'Donnell T, Mondet SF, Finnigan JP, Friedlander P, Sabado R, Bhardwaj N, Hammerbacher J. Abstract A022: Computational pipeline for a personalized genomic vaccine trial Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-A022  0.716
2016 Marron TU, Bhardwaj N, Hammerich L, Kim-Schulze S, Keler T, Davis T, Crowley E, Salazar AM, Brody J. Abstract LB-081: In situ vaccination of low-grade lymphoma with intratumoral Flt3L and poly-ICLC with low-dose radiotherapy Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-081  0.506
2016 Solovyov A, Tanne A, Ting D, Levine A, Bhardwaj N, Greenbaum B. Abstract 531: The landscape of immunostimulatory RNA transcription Cancer Research. 76: 531-531. DOI: 10.1158/1538-7445.Am2016-531  0.401
2016 Marron T, Bhardwaj N, Hammerich L, George F, Kim-Schulze S, Keler T, Davis T, Crowley E, Salazar A, Brody J. A Novel In Situ Vaccine: Intratumoral Flt3L and Poly-ICLC with Low-Dose Radiotherapy Clinical Lymphoma Myeloma and Leukemia. 16: S97-S98. DOI: 10.1016/J.Clml.2016.07.140  0.323
2015 Tanne A, Muniz LR, Puzio-Kuter A, Leonova KI, Gudkov AV, Ting DT, Monasson R, Cocco S, Levine AJ, Bhardwaj N, Greenbaum BD. Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 26575629 DOI: 10.1073/Pnas.1517584112  0.366
2015 Fernandez MV, Miller E, Krammer F, Gopal R, Greenbaum BD, Bhardwaj N. Ion efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells. Journal of Leukocyte Biology. PMID 26574023 DOI: 10.1189/Jlb.3A0614-313Rrr  0.336
2015 Gandhi RT, Kwon DS, Macklin EA, Shopis JR, McLean AP, McBrine N, Theresa Flynn AN, Peter L, Sbrolla A, Kaufmann DE, Porichis F, Walker BD, Bhardwaj N, Barouch DH, Kavanagh DG. Immunization of HIV-1-infected Persons with Autologous Dendritic Cells Transfected with mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26379068 DOI: 10.1097/Qai.0000000000000852  0.392
2015 Miller EA, Gopal R, Valdes V, Berger JS, Bhardwaj N, O'Brien MP. Soluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection. Aids (London, England). 29: 1287-96. PMID 26091297 DOI: 10.1097/Qad.0000000000000698  0.391
2015 Sabado RL, Bhardwaj N. Cancer immunotherapy: dendritic-cell vaccines on the move. Nature. 519: 300-1. PMID 25762139 DOI: 10.1038/Nature14211  0.753
2015 Sabado RL, Pavlick A, Gnjatic S, Cruz CM, Vengco I, Hasan F, Spadaccia M, Darvishian F, Chiriboga L, Holman RM, Escalon J, Muren C, Escano C, Yepes E, Sharpe D, ... ... Bhardwaj N, et al. Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with high-risk melanoma. Cancer Immunology Research. 3: 278-87. PMID 25633712 DOI: 10.1158/2326-6066.Cir-14-0202  0.754
2015 Moskalenko M, Pan M, Fu Y, de Moll EH, Hashimoto D, Mortha A, Leboeuf M, Jayaraman P, Bernardo S, Sikora AG, Wolchok J, Bhardwaj N, Merad M, Saenger Y. Requirement for innate immunity and CD90⁺ NK1.1⁻ lymphocytes to treat established melanoma with chemo-immunotherapy. Cancer Immunology Research. 3: 296-304. PMID 25600438 DOI: 10.1158/2326-6066.Cir-14-0120  0.439
2015 Norton TD, Miller EA, Bhardwaj N, Landau NR. Vpx-containing dendritic cell vaccine induces CTLs and reactivates latent HIV-1 in vitro. Gene Therapy. 22: 227-36. PMID 25567537 DOI: 10.1038/Gt.2014.117  0.515
2015 Bhardwaj N, Brody JD. Dendritic cells and lymphoma cells: come together right now. Blood. 125: 5-7. PMID 25554743 DOI: 10.1182/Blood-2014-11-606608  0.39
2015 Miller E, Spadaccia M, Sabado R, Chertova E, Bess J, Trubey CM, Holman RM, Salazar A, Lifson J, Bhardwaj N. Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy. Vaccine. 33: 388-95. PMID 25444812 DOI: 10.1016/J.Vaccine.2014.10.054  0.768
2015 Miller EA, Spadaccia MR, Norton T, Demmler M, Gopal R, O'Brien M, Landau N, Dubensky TW, Lauer P, Brockstedt DG, Bhardwaj N. Attenuated Listeria monocytogenes vectors overcome suppressive plasma factors during HIV infection to stimulate myeloid dendritic cells to promote adaptive immunity and reactivation of latent virus. Aids Research and Human Retroviruses. 31: 127-36. PMID 25376024 DOI: 10.1089/Aid.2014.0138  0.419
2015 Marron TU, Binder A, Bhardwaj N, Kim-Schulze S, Keler T, Davis T, Crowley E, Salazar AM, Brody J. In situ vaccine for low-grade lymphoma: Combination of intratumoral Flt3L and poly-ICLC with low-Dose radiotherapy. Journal of Clinical Oncology. 33: TPS3105-TPS3105. DOI: 10.1200/Jco.2015.33.15_Suppl.Tps3105  0.509
2015 Moogk D, Li T, Lee C, Pires Da Silva IED, Ma MW, Friedman EB, Vega-Saenz de Miera E, Darvishian F, Scanlon P, Perez-Garcia A, Pavlick AC, Bhardwaj N, Christos PJ, Osman I, Krogsgaard M. Association of melanoma expression of matrix metalloproteinase-23 with blunted tumor immunity and poor responses to immunotherapy. Journal of Clinical Oncology. 33: e20057-e20057. DOI: 10.1200/Jco.2015.33.15_Suppl.E20057  0.372
2015 Sabado RL, Pavlick AC, Gnjatic S, Hasan F, Spadaccia M, Oner BS, Dong H, Holman RM, Vengco I, Muren C, Escano C, Yepes E, Stein C, Jungbluth AA, Pan LS, ... ... Bhardwaj N, et al. Poly-ICLC as an adjuvant for NY-ESO-1 protein vaccination with or without Montanide ISA-51 VG in patients with melanoma. Journal of Clinical Oncology. 33: e14034-e14034. DOI: 10.1200/Jco.2015.33.15_Suppl.E14034  0.752
2015 Silva IEDPD, Gallois A, Lui KP, Shapiro RL, Pavlick AC, Bhardwaj N, Osman I. The effect of ipilimumab on natural killer cells identifies the subset of advanced melanoma patients with clinical response. Journal of Clinical Oncology. 33: 9065-9065. DOI: 10.1200/Jco.2015.33.15_Suppl.9065  0.411
2015 Galsky MD, Hahn NM, Albany C, Fleming MT, Starodub A, Twardowski P, Hauke RJ, Sonpavde G, Merad M, Gnjatic S, Bhardwaj N, Chippada-Venkata U, Oh WK, Kim-Schulze S. Impact of gemcitabine + cisplatin + ipilimumab on circulating immune cells in patients (pts) with metastatic urothelial cancer (mUC). Journal of Clinical Oncology. 33: 4586-4586. DOI: 10.1200/Jco.2015.33.15_Suppl.4586  0.417
2015 Tanne AJ, Muniz LR, Ting DT, Solovyov AV, Levine A, Greenbaum B, Bhardwaj N. Unraveling predicted immunomodulatory effects of novel cancer-associated non-coding RNAs Journal For Immunotherapy of Cancer. 3: P396. DOI: 10.1186/2051-1426-3-S2-P396  0.356
2015 Galsky MD, Noah H, Starodub A, Hauke RJ, Twardowski P, Fleming M, Qi J, Sonpavde G, Patel M, Zhu J, Chippada-Venkata U, Albany C, Wang L, Merad M, Oh W, ... Bhardwaj N, et al. Impact of chemotherapy alone, and chemotherapy plus ipilimumab, on circulating immune cells in patients with metastatic bladder cancer Journal For Immunotherapy of Cancer. 3: P257. DOI: 10.1186/2051-1426-3-S2-P257  0.389
2015 Perumal D, Lagana' A, Rubinsteyn A, Finnigan JP, Kuo P, Leshchenko VV, Chari A, Cho HJ, Jagannath S, Dudley J, Hammerbacher J, Schadt E, Bhardwaj N, Parekh S. Patient-Specific Mutation-Derived Tumor Antigens As Targets for Cancer Immunotherapy in Multiple Myeloma Blood. 126: 1851-1851. DOI: 10.1182/Blood.V126.23.1851.1851  0.391
2015 Bhardwaj N. Abstract IA24: Vaccines targeting innate immune cells Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-Ia24  0.522
2015 Marron T, Bhardwaj N, Crowley E, Keler T, Davis T, Salazar A, Brody J. Abstract IA03: Turning a tumor into a vaccine factory: In situ vaccination for low-grade lymphoma Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-Ia03  0.519
2014 Gallois A, Silva I, Osman I, Bhardwaj N. Reversal of natural killer cell exhaustion by TIM-3 blockade. Oncoimmunology. 3: e946365. PMID 25964857 DOI: 10.4161/21624011.2014.946365  0.423
2014 Moogk D, da Silva IP, Ma MW, Friedman EB, de Miera EV, Darvishian F, Scanlon P, Perez-Garcia A, Pavlick AC, Bhardwaj N, Christos PJ, Osman I, Krogsgaard M. Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy. Journal of Translational Medicine. 12: 342. PMID 25491880 DOI: 10.1186/S12967-014-0342-7  0.373
2014 Godefroy E, Gallois A, Idoyaga J, Merad M, Tung N, Monu N, Saenger Y, Fu Y, Ravindran R, Pulendran B, Jotereau F, Trombetta S, Bhardwaj N. Activation of toll-like receptor-2 by endogenous matrix metalloproteinase-2 modulates dendritic-cell-mediated inflammatory responses. Cell Reports. 9: 1856-70. PMID 25466255 DOI: 10.1016/J.Celrep.2014.10.067  0.408
2014 Miller E, Bhardwaj N. Advances in dendritic cell immunotherapies for HIV-1 infection. Expert Opinion On Biological Therapy. 14: 1545-9. PMID 25143151 DOI: 10.1517/14712598.2014.950652  0.434
2014 Harshman LC, Drake CG, Wargo JA, Sharma P, Bhardwaj N. Cancer immunotherapy highlights from the 2014 ASCO Meeting. Cancer Immunology Research. 2: 714-9. PMID 25092813 DOI: 10.1158/2326-6066.Cir-14-0119  0.396
2014 Adams S, Novik Y, Oratz R, Axelrod D, Speyer J, Tiersten A, Goldberg JD, Bhardwaj N, Unutmaz D, Demaria S, Formenti S. Clinical trial evidence of the antitumor activity of topical imiquimod for breast cancer skin metastases. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3204-5. PMID 25092780 DOI: 10.1200/Jco.2014.56.1282  0.356
2014 Fernandez MV, Miller EA, Bhardwaj N. Activation and measurement of NLRP3 inflammasome activity using IL-1β in human monocyte-derived dendritic cells. Journal of Visualized Experiments : Jove. PMID 24894187 DOI: 10.3791/51284  0.391
2014 Salazar AM, Erlich RB, Mark A, Bhardwaj N, Herberman RB. Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC: case report, hypothesis, and clinical trial. Cancer Immunology Research. 2: 720-4. PMID 24801836 DOI: 10.1158/2326-6066.Cir-14-0024  0.484
2014 da Silva IP, Gallois A, Jimenez-Baranda S, Khan S, Anderson AC, Kuchroo VK, Osman I, Bhardwaj N. Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade. Cancer Immunology Research. 2: 410-22. PMID 24795354 DOI: 10.1158/2326-6066.Cir-13-0171  0.463
2014 Sivendran S, Chang R, Pham L, Phelps RG, Harcharik ST, Hall LD, Bernardo SG, Moskalenko MM, Sivendran M, Fu Y, de Moll EH, Pan M, Moon JY, Arora S, Cohain A, ... ... Bhardwaj N, et al. Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable disease. The Journal of Investigative Dermatology. 134: 2202-11. PMID 24522433 DOI: 10.1038/Jid.2014.85  0.317
2014 Manches O, Frleta D, Bhardwaj N. Dendritic cells in progression and pathology of HIV infection. Trends in Immunology. 35: 114-22. PMID 24246474 DOI: 10.1016/J.It.2013.10.003  0.405
2014 Bloch N, O'Brien M, Norton TD, Polsky SB, Bhardwaj N, Landau NR. HIV type 1 infection of plasmacytoid and myeloid dendritic cells is restricted by high levels of SAMHD1 and cannot be counteracted by Vpx. Aids Research and Human Retroviruses. 30: 195-203. PMID 23924154 DOI: 10.1089/Aid.2013.0119  0.433
2014 Bhardwaj N, Merad M, Kim-Schulze S, Crowley E, Keler T, Davis T, Brody J. Flt3L-primed in situ vaccine for patients with low-grade lymphoma: tumor regression at untreated sites (NCT01976585) F1000research. 5. DOI: 10.7490/F1000Research.1097381.1  0.373
2014 Sabado RL, Pavlick AC, Gnjatic S, Ott PA, Hasan F, Spadaccia M, Vengco I, Holman RM, Muren C, Escano C, Yepes E, Stein C, Jungbluth AA, Pan LS, Venhaus RR, ... Bhardwaj N, et al. Phase I/II study of the TLR3 agonist poly-ICLC as an adjuvant for NY-ESO-1 protein vaccination with or without Montanide ISA-51 vg in patients with melanoma. Journal of Clinical Oncology. 32: TPS9119-TPS9119. DOI: 10.1200/Jco.2014.32.15_Suppl.Tps9119  0.75
2014 Pavlick AC, Chandra S, Stein C, Madden KM, Kannan R, Escano C, Muren C, Yepes E, Sabado RL, Bhardwaj N. Phase II study of low-dose cyclophosphamide and ipilimumab in metastatic melanoma. Journal of Clinical Oncology. 32: e20025-e20025. DOI: 10.1200/Jco.2014.32.15_Suppl.E20025  0.669
2014 Saenger YM, Sabado RL, Holman RM, Lehrer D, Salazar AM, Bhardwaj N. Treatment of solid tumors with intratumoral poly-ICLC: A phase II clinical study. Journal of Clinical Oncology. 32: e14010-e14010. DOI: 10.1200/Jco.2014.32.15_Suppl.E14010  0.671
2014 Silva IEDPD, Gallois A, Lui KP, Shapiro RL, Berman RS, Pavlick AC, Zhong J, Bhardwaj N, Osman I. Association of natural killer (NK) cell exhaustion with melanoma progression. Journal of Clinical Oncology. 32: 9099-9099. DOI: 10.1200/Jco.2014.32.15_Suppl.9099  0.404
2014 Moogk D, Ma MW, Pires Da Silva IED, Friedman EB, Vega-Saenz de Miera E, Darvishian F, Perez-Garcia A, Scanlon P, Pavlick AC, Bhardwaj N, Christos PJ, Osman I, Krogsgaard M. Matrix metalloproteinase-23 as a new immunotherapeutic checkpoint target in melanoma. Journal of Clinical Oncology. 32: 3030-3030. DOI: 10.1200/Jco.2014.32.15_Suppl.3030  0.377
2014 Bhardwaj N, Merad M, Kim-Schulze S, Crowley B, Davis T, Keler T, Salazar A, Brody J. Converting tumors into vaccine manufacturing factories: DC recruitment, activation and clinical responses with a flt3L-primed in situ vaccine for low-grade lymphoma [nct01976585] Journal For Immunotherapy of Cancer. 2: P45. DOI: 10.1186/2051-1426-2-S3-P45  0.441
2014 Pires da Silva I, Gallois A, Jimenez-Baranda S, Anderson A, Kuchroo V, Osman I, Bhardwaj N. Melanoma progression is associated with NK cell exhaustion Journal For Immunotherapy of Cancer. 2: O6. DOI: 10.1186/2051-1426-2-S3-O6  0.395
2014 Godefroy E, Bhardwaj N. Activation of Toll-like receptor-2 by tumor associated matrix metalloproteinase-2 modulates dendritic cell function Journal For Immunotherapy of Cancer. 2: 1-1. DOI: 10.1186/2051-1426-2-S3-O21  0.371
2014 Marron T, Bhardwaj N, Crowley E, Keler T, Davis TA, Brody J. Turning a Tumor into a Vaccine Factory: In Situ Vaccination for Low-Grade Lymphoma Blood. 124: 5473-5473. DOI: 10.1182/Blood.V124.21.5473.5473  0.524
2014 Godefroy E, Gallois A, Idoyaga J, Jotereau F, Bhardwaj N. Abstract LB-252: Matrix metalloproteinase-2 dysregulate anti-tumor immunity Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-252  0.485
2014 Gallois A, Silva IPD, Jimenez S, Osman I, Bhardwaj N. Abstract 4862: Reversal of NK cell exhaustion in advanced melanoma patients by Tim-3 blockade Cancer Research. 74: 4862-4862. DOI: 10.1158/1538-7445.Am2014-4862  0.462
2013 Gallois A, Bhardwaj N. Dendritic cell-targeted approaches to modulate immune dysfunction in the tumor microenvironment. Frontiers in Immunology. 4: 436. PMID 24339825 DOI: 10.3389/Fimmu.2013.00436  0.509
2013 Ott PA, Bhardwaj N. Impact of MAPK Pathway Activation in BRAF(V600) Melanoma on T Cell and Dendritic Cell Function. Frontiers in Immunology. 4: 346. PMID 24194739 DOI: 10.3389/Fimmu.2013.00346  0.484
2013 Miller E, Bhardwaj N. A bloody mess: dendritic cells use hemophagocytosis to regulate viral inflammation. Immunity. 39: 429-31. PMID 24054326 DOI: 10.1016/J.Immuni.2013.08.024  0.414
2013 Sabado RL, Miller E, Spadaccia M, Vengco I, Hasan F, Bhardwaj N. Preparation of tumor antigen-loaded mature dendritic cells for immunotherapy. Journal of Visualized Experiments : Jove. PMID 23928481 DOI: 10.3791/50085  0.769
2013 Miller E, Bhardwaj N. Dendritic cell dysregulation during HIV-1 infection. Immunological Reviews. 254: 170-89. PMID 23772620 DOI: 10.1111/Imr.12082  0.45
2013 Sabado RL, Bhardwaj N. Dendritic cell immunotherapy. Annals of the New York Academy of Sciences. 1284: 31-45. PMID 23651191 DOI: 10.1111/nyas.12125  0.76
2013 Gnjatic S, Bhardwaj N. Antigen depots: T cell traps? Nature Medicine. 19: 397-8. PMID 23558621 DOI: 10.1038/Nm.3113  0.475
2013 Parrish NF, Gao F, Li H, Giorgi EE, Barbian HJ, Parrish EH, Zajic L, Iyer SS, Decker JM, Kumar A, Hora B, Berg A, Cai F, Hopper J, Denny TN, ... ... Bhardwaj N, et al. Phenotypic properties of transmitted founder HIV-1. Proceedings of the National Academy of Sciences of the United States of America. 110: 6626-33. PMID 23542380 DOI: 10.1073/Pnas.1304288110  0.402
2013 Ruiz-Riol M, Mothe B, Gandhi RT, Bhardwaj N, Scadden DT, Sanchez-Merino V, Brander C. Influenza, but not HIV-specific CTL epitopes, elicits delayed-type hypersensitivity (DTH) reactions in HIV-infected patients. European Journal of Immunology. 43: 1545-54. PMID 23504637 DOI: 10.1002/Eji.201242732  0.424
2013 O'Brien M, Montenont E, Hu L, Nardi MA, Valdes V, Merolla M, Gettenberg G, Cavanagh K, Aberg JA, Bhardwaj N, Berger JS. Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study. Journal of Acquired Immune Deficiency Syndromes (1999). 63: 280-8. PMID 23406976 DOI: 10.1097/Qai.0B013E31828A292C  0.316
2013 Ott PA, Henry T, Baranda SJ, Frleta D, Manches O, Bogunovic D, Bhardwaj N. Inhibition of both BRAF and MEK in BRAF(V600E) mutant melanoma restores compromised dendritic cell (DC) function while having differential direct effects on DC properties. Cancer Immunology, Immunotherapy : Cii. 62: 811-22. PMID 23306863 DOI: 10.1007/S00262-012-1389-Z  0.715
2013 O'Brien M, Manches O, Bhardwaj N. Plasmacytoid dendritic cells in HIV infection. Advances in Experimental Medicine and Biology. 762: 71-107. PMID 22975872 DOI: 10.1007/978-1-4614-4433-6_3  0.401
2013 Finnigan JP, Rubinsteyn A, Nathanson T, Akers N, Bhardwaj N, Hammerbacher J, Losic B, Schadt E. Personalized neoantigen vaccination with synthetic long peptides F1000research. 5. DOI: 10.7490/F1000Research.1111311.1  0.303
2013 Sivendran S, Chang RR, Harcharik S, Hall L, Bernardo S, Moskalenko M, Phelps R, Sivendran M, Cohain A, DiFeo A, Parides M, Lebwohl M, Friedlander P, Banchereau J, Bhardwaj N, et al. Immune gene expression in primary melanomas to predict lower risk of recurrence and death. Journal of Clinical Oncology. 31: 3014-3014. DOI: 10.1200/Jco.2013.31.15_Suppl.3014  0.363
2013 Silva IPD, Gallois A, Osman I, Bhardwaj N. Abstract 465: Characterization of NK cell exhaustion in melanoma at different stages. Cancer Research. 73: 465-465. DOI: 10.1158/1538-7445.Am2013-465  0.413
2013 Godefroy E, Gallois A, Manches O, Ensanyat S, Jotereau F, Bhardwaj N. Abstract 457: Matrix metalloproteinase-2 modulates antitumor immunity. Cancer Research. 73: 457-457. DOI: 10.1158/1538-7445.Am2013-457  0.486
2012 Frleta D, Ochoa CE, Kramer HB, Khan SA, Stacey AR, Borrow P, Kessler BM, Haynes BF, Bhardwaj N. HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44. The Journal of Clinical Investigation. 122: 4685-97. PMID 23160198 DOI: 10.1172/Jci64439  0.398
2012 Miller EA, Spadaccia MR, OʼBrien MP, Rolnitzky L, Sabado R, Manches O, Frleta D, Bhardwaj N. Plasma factors during chronic HIV-1 infection impair IL-12 secretion by myeloid dendritic cells via a virus-independent pathway. Journal of Acquired Immune Deficiency Syndromes (1999). 61: 535-44. PMID 22902724 DOI: 10.1097/Qai.0B013E31826Afbce  0.721
2012 Manches O, Fernandez MV, Plumas J, Chaperot L, Bhardwaj N. Activation of the noncanonical NF-κB pathway by HIV controls a dendritic cell immunoregulatory phenotype. Proceedings of the National Academy of Sciences of the United States of America. 109: 14122-7. PMID 22879398 DOI: 10.1073/Pnas.1204032109  0.385
2012 Adams S, Kozhaya L, Martiniuk F, Meng TC, Chiriboga L, Liebes L, Hochman T, Shuman N, Axelrod D, Speyer J, Novik Y, Tiersten A, Goldberg JD, Formenti SC, Bhardwaj N, et al. Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 6748-57. PMID 22767669 DOI: 10.1158/1078-0432.Ccr-12-1149  0.381
2012 Godefroy E, Bhardwaj N. Dysregulation of anti-tumor immunity by the matrix metalloproteinase-2. Oncoimmunology. 1: 109-111. PMID 22720227 DOI: 10.4161/Onci.1.1.17994  0.405
2012 Ma MW, Medicherla RC, Qian M, Vega-Saenz de Miera E, Friedman EB, Berman RS, Shapiro RL, Pavlick AC, Ott PA, Bhardwaj N, Shao Y, Osman I, Darvishian F. Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 25: 1000-10. PMID 22425909 DOI: 10.1038/Modpathol.2012.43  0.336
2012 Jiménez-Baranda S, Silva IP, Bhardwaj N. Plasmacytoid dendritic cells lead the charge against tumors. The Journal of Clinical Investigation. 122: 481-4. PMID 22251700 DOI: 10.1172/Jci61345  0.432
2012 Gallois A, Godefroy E, Manches O, Bhardwaj N. Effect of matrix metalloproteinase-2 on CD8+ T cell and NK cell responses. Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.E21081  0.301
2012 Pires Da Silva IED, Jimenez-Baranda S, Gallois A, Kuchroo V, Osman I, Bhardwaj N. Tim-3 expression and function in natural killer cells from advanced melanoma patients. Journal of Clinical Oncology. 30: 8571-8571. DOI: 10.1200/Jco.2012.30.15_Suppl.8571  0.431
2012 Sabado RL, Pavlick AC, Gnjatic S, Cruz CM, Vengco I, Hasan F, Darvishian F, Chiriboga L, Holman RM, Escalon J, Muren C, Escano C, Yepes E, Sharpe D, Adams S, ... ... Bhardwaj N, et al. Phase I/II study of resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma. Journal of Clinical Oncology. 30: 2589-2589. DOI: 10.1200/Jco.2012.30.15_Suppl.2589  0.747
2012 Godefroy E, Gallois A, Manches O, Jotereau F, Bhardwaj N. Effect of matrix metalloproteinase-2 on antitumor immunity. Journal of Clinical Oncology. 30: 2570-2570. DOI: 10.1200/Jco.2012.30.15_Suppl.2570  0.374
2012 Manches O, Fernandez MV, Plumas J, Chaperot L, Bhardwaj N. HIV triggers immunoregulatory dendritic cells and regulatory T cells through the non-canonical NF-kB pathway Retrovirology. 9: 184. DOI: 10.1186/1742-4690-9-S2-P184  0.385
2012 Frleta D, Ochoa C, Kramer H, Khan S, Stacey A, Borrow P, Kessler B, Haynes B, Bhardwaj N. Apoptotic microparticles generated during acute HIV-1 infection inhibit human dendritic cells via CD44 Retrovirology. 9: 183. DOI: 10.1186/1742-4690-9-S2-P183  0.395
2012 Bhardwaj N, Godefroy E, Jotereau F, Manches O, Gallois A, Goldberg J. Abstract SY40-02: Interplay between microenvironment and cancers Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Sy40-02  0.442
2012 Silva IPd, Jimenez-Baranda S, Gallois A, Kuchroo VK, Osman I, Bhardwaj N. Abstract 5410: Tim-3 expression and function in natural killer cells from metastatic melanoma patients Cancer Research. 72: 5410-5410. DOI: 10.1158/1538-7445.Am2012-5410  0.471
2011 Silva IP, Gallois A, Jimenez-Baranda S, Godefroy E, Osman I, Bhardwaj N. NK cell dysregulation in metastatic melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e21078. PMID 28022215 DOI: 10.1200/Jco.2011.29.15_Suppl.E21078  0.441
2011 Medicherla RC, Ma MW, Qian M, Vega-Saenz de Miera E, Berman RS, Shapiro RL, Pavlick AC, Bhardwaj N, Shao Y, Osman I, Darvishian F. Impact of immune modulation on sentinel lymph node positivity and outcome in melanoma patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 8561. PMID 28021039 DOI: 10.1200/Jco.2011.29.15_Suppl.8561  0.337
2011 Gaziel-Sovran A, Segura MF, Di Micco R, Collins MK, Hanniford D, Vega-Saenz de Miera E, Rakus JF, Dankert JF, Shang S, Kerbel RS, Bhardwaj N, Shao Y, Darvishian F, Zavadil J, Erlebacher A, et al. miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell. 20: 104-18. PMID 21741600 DOI: 10.1016/J.Ccr.2011.05.027  0.315
2011 Bogunovic D, Manches O, Godefroy E, Yewdall A, Gallois A, Salazar AM, Marie I, Levy DE, Bhardwaj N. TLR4 engagement during TLR3-induced proinflammatory signaling in dendritic cells promotes IL-10-mediated suppression of antitumor immunity. Cancer Research. 71: 5467-76. PMID 21730023 DOI: 10.1158/0008-5472.Can-10-3988  0.804
2011 Nardiello T, Jungbluth AA, Mei A, Diliberto M, Huang X, Dabrowski A, Andrade VC, Wasserstrum R, Ely S, Niesvizky R, Pearse R, Coleman M, Jayabalan DS, Bhardwaj N, Old LJ, et al. MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4309-19. PMID 21565982 DOI: 10.1158/1078-0432.Ccr-10-1820  0.373
2011 Sunseri N, O'Brien M, Bhardwaj N, Landau NR. Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells. Journal of Virology. 85: 6263-74. PMID 21507971 DOI: 10.1128/Jvi.00346-11  0.362
2011 Yuan J, Ginsberg B, Page D, Li Y, Rasalan T, Gallardo HF, Xu Y, Adams S, Bhardwaj N, Busam K, Old LJ, Allison JP, Jungbluth A, Wolchok JD. CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases. Cancer Immunology, Immunotherapy : Cii. 60: 1137-46. PMID 21465316 DOI: 10.1007/S00262-011-1011-9  0.472
2011 Godefroy E, Manches O, Dréno B, Hochman T, Rolnitzky L, Labarrière N, Guilloux Y, Goldberg J, Jotereau F, Bhardwaj N. Matrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory T(H)2 cells via an IL-12- and OX40L-dependent pathway. Cancer Cell. 19: 333-46. PMID 21397857 DOI: 10.1016/J.Ccr.2011.01.037  0.384
2011 Altfeld M, Fadda L, Frleta D, Bhardwaj N. DCs and NK cells: critical effectors in the immune response to HIV-1. Nature Reviews. Immunology. 11: 176-86. PMID 21350578 DOI: 10.1038/Nri2935  0.441
2011 O'Brien M, Manches O, Sabado RL, Baranda SJ, Wang Y, Marie I, Rolnitzky L, Markowitz M, Margolis DM, Levy D, Bhardwaj N. Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-α-producing and partially matured phenotype. The Journal of Clinical Investigation. 121: 1088-101. PMID 21339641 DOI: 10.1172/Jci44960  0.711
2011 Jimenez-Baranda S, Greenbaum B, Manches O, Handler J, Rabadán R, Levine A, Bhardwaj N. Oligonucleotide motifs that disappear during the evolution of influenza virus in humans increase alpha interferon secretion by plasmacytoid dendritic cells. Journal of Virology. 85: 3893-904. PMID 21307198 DOI: 10.1128/Jvi.01908-10  0.378
2010 Feig JE, Pineda-Torra I, Sanson M, Bradley MN, Vengrenyuk Y, Bogunovic D, Gautier EL, Rubinstein D, Hong C, Liu J, Wu C, van Rooijen N, Bhardwaj N, Garabedian M, Tontonoz P, et al. LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. The Journal of Clinical Investigation. 120: 4415-24. PMID 21041949 DOI: 10.1172/Jci38911  0.663
2010 Gnjatic S, Sawhney NB, Bhardwaj N. Toll-like receptor agonists: are they good adjuvants? Cancer Journal (Sudbury, Mass.). 16: 382-91. PMID 20693851 DOI: 10.1097/Ppo.0B013E3181Eaca65  0.545
2010 Sabado RL, O'Brien M, Subedi A, Qin L, Hu N, Taylor E, Dibben O, Stacey A, Fellay J, Shianna KV, Siegal F, Shodell M, Shah K, Larsson M, Lifson J, ... ... Bhardwaj N, et al. Evidence of dysregulation of dendritic cells in primary HIV infection. Blood. 116: 3839-52. PMID 20693428 DOI: 10.1182/Blood-2010-03-273763  0.745
2010 Gallois A, Bhardwaj N. A needle in the 'cancer vaccine' haystack. Nature Medicine. 16: 854-6. PMID 20689546 DOI: 10.1038/Nm0810-854  0.42
2010 Yewdall AW, Drutman SB, Jinwala F, Bahjat KS, Bhardwaj N. CD8+ T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cells. Plos One. 5: e11144. PMID 20585396 DOI: 10.1371/Journal.Pone.0011144  0.841
2010 Sabado RL, Bhardwaj N. Directing dendritic cell immunotherapy towards successful cancer treatment. Immunotherapy. 2: 37-56. PMID 20473346 DOI: 10.2217/Imt.09.43  0.779
2010 Che KF, Sabado RL, Shankar EM, Tjomsland V, Messmer D, Bhardwaj N, Lifson JD, Larsson M. HIV-1 impairs in vitro priming of naïve T cells and gives rise to contact-dependent suppressor T cells. European Journal of Immunology. 40: 2248-58. PMID 20455275 DOI: 10.1002/Eji.201040377  0.741
2010 Lendvai N, Gnjatic S, Ritter E, Mangone M, Austin W, Reyner K, Jayabalan D, Niesvizky R, Jagannath S, Bhardwaj N, Chen-Kiang S, Old LJ, Cho HJ. Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients. Cancer Immunity. 10: 4. PMID 20108890  0.304
2010 Adams S, Dewan Z, Meng T, Goldberg JD, Tiersten A, Bhardwaj N, Formenti S, Demaria S. Evaluation of toll-like receptor (TLR)-7 agonist imiquimod applied topically to breast cancer chest wall recurrences or skin metastases. Journal of Clinical Oncology. 28: TPS138-TPS138. DOI: 10.1200/Jco.2010.28.15_Suppl.Tps138  0.371
2010 Bogunovic D, Manches O, Yewdall A, Marie I, Levy DE, Bhardwaj N. Effect of TLR4 engagement on TLR3-induced proinflammatory signaling in dendritic cells through IL-10, STAT3, and p38-dependent pathways and on antimelanoma CD8+ T-cell priming. Journal of Clinical Oncology. 28: 8568-8568. DOI: 10.1200/Jco.2010.28.15_Suppl.8568  0.798
2010 Bhardwaj N. Abstract SY03-03: Modulating innate and adaptive immunity through the manipulation of dendritic cells Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Sy03-03  0.571
2010 Bogunovic D, Bhardwaj N. Reply to Murali and Scolyer: Immune profile and mitotic index in advanced melanoma Proceedings of the National Academy of Sciences of the United States of America. 107. DOI: 10.1073/Pnas.1001120107  0.619
2010 Marzocchetti A, Lima M, Tompkins T, Kavanagh DG, Gandhi RT, O'Neill DW, Bhardwaj N, Koralnik IJ. Corrigendum to “Efficient in vitro expansion of JC virus-specific CD8+ T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy” [Virology 383 (2009) 173–177] Virology. 396: 349-350. DOI: 10.1016/J.Virol.2009.10.038  0.417
2009 Bogunovic D, O'Neill D, Belitskaya-Levy I, Vacic V, Adams S, Darvishian F, Pavlick A, Zavadil J, Osman I, Bhardwaj N. Use of gene expression profile and mitotic index of metastatic melanoma lesions as an adjunct to TNM staging in predicting patient survival. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 9014. PMID 27962377 DOI: 10.1200/Jco.2009.27.15_Suppl.9014  0.609
2009 O'Neill DW, Adams S, Goldberg JD, Escalon JB, Rolnitzky LM, Cruz CM, Angiulli A, Old L, Pavlick AC, Bhardwaj N. Comparison of the immunogenicity of Montanide ISA 51 adjuvant and cytokine-matured dendritic cells in a randomized controlled clinical trial of melanoma vaccines. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 3002. PMID 27962052 DOI: 10.1200/Jco.2009.27.15_Suppl.3002  0.467
2009 Godefroy E, Guilloux Y, Jotereau F, Bhardwaj N. MMP-2: A novel target for antitumor immune therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 3053. PMID 27962001 DOI: 10.1200/Jco.2009.27.15_Suppl.3053  0.422
2009 Manches O, Bhardwaj N. Resolution of immune activation defines nonpathogenic SIV infection. The Journal of Clinical Investigation. 119: 3512-5. PMID 19959871 DOI: 10.1172/Jci41509  0.338
2009 Bogunovic D, O'Neill DW, Belitskaya-Levy I, Vacic V, Yu YL, Adams S, Darvishian F, Berman R, Shapiro R, Pavlick AC, Lonardi S, Zavadil J, Osman I, Bhardwaj N. Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. Proceedings of the National Academy of Sciences of the United States of America. 106: 20429-34. PMID 19915147 DOI: 10.1073/Pnas.0905139106  0.678
2009 Khan S, Greenberg JD, Bhardwaj N. Dendritic cells as targets for therapy in rheumatoid arthritis. Nature Reviews. Rheumatology. 5: 566-71. PMID 19798032 DOI: 10.1038/Nrrheum.2009.185  0.484
2009 Bioley G, Dousset C, Yeh A, Dupont B, Bhardwaj N, Mears G, Old LJ, Ayyoub M, Valmori D. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4467-74. PMID 19531622 DOI: 10.1158/1078-0432.Ccr-09-0582  0.508
2009 Gandhi RT, O'Neill D, Bosch RJ, Chan ES, Bucy RP, Shopis J, Baglyos L, Adams E, Fox L, Purdue L, Marshak A, Flynn T, Masih R, Schock B, Mildvan D, ... ... Bhardwaj N, et al. A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy. Vaccine. 27: 6088-94. PMID 19450647 DOI: 10.1016/J.Vaccine.2009.05.016  0.386
2009 Alzabin S, Bhardwaj N, Kiefer F, Sawasdikosol S, Burakoff S. Hematopoietic progenitor kinase 1 is a negative regulator of dendritic cell activation. Journal of Immunology (Baltimore, Md. : 1950). 182: 6187-94. PMID 19414772 DOI: 10.4049/Jimmunol.0802631  0.434
2009 Bioley G, Guillaume P, Luescher I, Bhardwaj N, Mears G, Old L, Valmori D, Ayyoub M. Vaccination with a recombinant protein encoding the tumor-specific antigen NY-ESO-1 elicits an A2/157-165-specific CTL repertoire structurally distinct and of reduced tumor reactivity than that elicited by spontaneous immune responses to NY-ESO-1-expressing Tumors. Journal of Immunotherapy (Hagerstown, Md. : 1997). 32: 161-8. PMID 19238015 DOI: 10.1097/Cji.0B013E31819302F6  0.467
2009 Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S, Zakrzewski J, Blochin E, Rose A, Bogunovic D, Polsky D, Wei J, Lee P, Belitskaya-Levy I, Bhardwaj N, et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proceedings of the National Academy of Sciences of the United States of America. 106: 1814-9. PMID 19188590 DOI: 10.1073/Pnas.0808263106  0.609
2009 Lubong Sabado R, Kavanagh DG, Kaufmann DE, Fru K, Babcock E, Rosenberg E, Walker B, Lifson J, Bhardwaj N, Larsson M. In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4 T cells in acute HIV-1 infection. Plos One. 4: e4256. PMID 19165342 DOI: 10.1371/Journal.Pone.0004256  0.416
2009 Bioley G, Guillaume P, Luescher I, Yeh A, Dupont B, Bhardwaj N, Mears G, Old LJ, Valmori D, Ayyoub M. HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccine. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 299-306. PMID 19118058 DOI: 10.1158/1078-0432.Ccr-08-1747  0.485
2009 Marzocchetti A, Lima M, Tompkins T, Kavanagh DG, Gandhi RT, O'Neill DW, Bhardwaj N, Koralnik IJ. Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy. Virology. 383: 173-7. PMID 19062062 DOI: 10.1016/J.Virol.2008.10.046  0.447
2009 Miller E, Bhardwaj N, O’Brien M. Dendritic cell function in HIV infection Hiv Therapy. 3: 527-537. DOI: 10.2217/Hiv.09.34  0.448
2009 Manches O, Munn D, Fallahi A, Lifson J, Chaperot L, Plumas J, Bhardwaj N. P16-52. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism Retrovirology. 6: 281. DOI: 10.1186/1742-4690-6-S3-P281  0.478
2009 Frleta D, O'Brien M, Haynes B, Kessler B, Bhardwaj N. P10-05. Suppression of human dendritic cell function during acute HIV infection Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P136  0.473
2008 Bogunovic D, O'Neill D, Adams S, Wang J, Darvishian F, Pavlick AC, Shapiro RL, Zavadil J, Osman I, Bhardwaj N. Gene expression profile for metastatic melanoma and patient survival. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 9049. PMID 27950725 DOI: 10.1200/Jco.2008.26.15_Suppl.9049  0.615
2008 Minkis K, Kavanagh D, O'Neill D, Alter G, Sunderji S, Adams S, Walker B, Pavlick AC, Gandhi R, Bhardwaj N. Transfection of dendritic cells (DCs) with mRNA encoding IL-12p70 enhances anti-tumor immunity in melanoma patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 22217. PMID 27950264 DOI: 10.1200/Jco.2008.26.15_Suppl.22217  0.732
2008 Borrow P, Bhardwaj N. Innate immune responses in primary HIV-1 infection. Current Opinion in Hiv and Aids. 3: 36-44. PMID 19372942 DOI: 10.1097/Coh.0B013E3282F2Bce7  0.318
2008 Skoberne M, Yewdall A, Bahjat KS, Godefroy E, Lauer P, Lemmens E, Liu W, Luckett W, Leong M, Dubensky TW, Brockstedt DG, Bhardwaj N. KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity. The Journal of Clinical Investigation. 118: 3990-4001. PMID 19033668 DOI: 10.1172/Jci31350  0.829
2008 Minkis K, Kavanagh DG, Alter G, Bogunovic D, O'Neill D, Adams S, Pavlick A, Walker BD, Brockman MA, Gandhi RT, Bhardwaj N. Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells. Cancer Research. 68: 9441-50. PMID 19010919 DOI: 10.1158/0008-5472.Can-08-0900  0.804
2008 Manches O, Munn D, Fallahi A, Lifson J, Chaperot L, Plumas J, Bhardwaj N. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism. The Journal of Clinical Investigation. 118: 3431-9. PMID 18776940 DOI: 10.1172/Jci34823  0.434
2008 Adams S, O'Neill DW, Nonaka D, Hardin E, Chiriboga L, Siu K, Cruz CM, Angiulli A, Angiulli F, Ritter E, Holman RM, Shapiro RL, Berman RS, Berner N, Shao Y, ... ... Bhardwaj N, et al. Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant. Journal of Immunology (Baltimore, Md. : 1950). 181: 776-84. PMID 18566444 DOI: 10.4049/Jimmunol.181.1.776  0.515
2008 Mathew S, Bauer KL, Fischoeder A, Bhardwaj N, Oliver SJ. The anergic state in sarcoidosis is associated with diminished dendritic cell function. Journal of Immunology (Baltimore, Md. : 1950). 181: 746-55. PMID 18566441 DOI: 10.4049/Jimmunol.181.1.746  0.398
2008 Ngumbela KC, Ryan KP, Sivamurthy R, Brockman MA, Gandhi RT, Bhardwaj N, Kavanagh DG. Quantitative effect of suboptimal codon usage on translational efficiency of mRNA encoding HIV-1 gag in intact T cells. Plos One. 3: e2356. PMID 18523584 DOI: 10.1371/Journal.Pone.0002356  0.322
2008 Adams S, Lowes MA, O'Neill DW, Schachterle S, Romero P, Bhardwaj N. Lack of functionally active Melan-A(26-35)-specific T cells in the blood of HLA-A2+ vitiligo patients. The Journal of Investigative Dermatology. 128: 1977-80. PMID 18337837 DOI: 10.1038/Jid.2008.31  0.424
2008 Skoberne M, Yewdall A, Bahjat KS, Lemmens E, Liu W, Lauer P, Luckett W, Dubensky TW, Brockstedt DG, Bhardwaj N. Use of KBMA Listeria monocytogenes as an antigen loading platform for dendritic cell-mediated induction of antitumor immunity Journal of Clinical Oncology. 26: 3044-3044. DOI: 10.1200/Jco.2008.26.15_Suppl.3044  0.839
2007 Lakshmanan V, Alter G, Altfeld M, Bhardwaj N. Biology of plasmacytoid dendritic cells and natural killer cells in HIV-1 infection. Current Opinion in Hiv and Aids. 2: 189-200. PMID 19372886 DOI: 10.1097/Coh.0B013E32810996Db  0.393
2007 O'Neill DW, Bhardwaj N. Exploiting dendritic cells for active immunotherapy of cancer and chronic infections. Molecular Biotechnology. 36: 131-41. PMID 17914192 DOI: 10.1385/1-59259-862-5:001  0.498
2007 O'Neill DW, Bhardwaj N. Armed and ready: how effector T cells deploy in reactive lymph nodes to modulate immunity. Nature Immunology. 8: 679-81. PMID 17579644 DOI: 10.1038/Ni0707-679  0.378
2007 Sabado RL, Babcock E, Kavanagh DG, Tjomsland V, Walker BD, Lifson JD, Bhardwaj N, Larsson M. Pathways utilized by dendritic cells for binding, uptake, processing and presentation of antigens derived from HIV-1. European Journal of Immunology. 37: 1752-63. PMID 17534864 DOI: 10.1002/Eji.200636981  0.76
2007 Valmori D, Souleimanian NE, Tosello V, Bhardwaj N, Adams S, O'Neill D, Pavlick A, Escalon JB, Cruz CM, Angiulli A, Angiulli F, Mears G, Vogel SM, Pan L, Jungbluth AA, et al. Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming. Proceedings of the National Academy of Sciences of the United States of America. 104: 8947-52. PMID 17517626 DOI: 10.1073/Pnas.0703395104  0.496
2007 Bhardwaj N. Harnessing the immune system to treat cancer. The Journal of Clinical Investigation. 117: 1130-6. PMID 17476342 DOI: 10.1172/Jci32136  0.465
2007 Velazquez EF, Yancovitz M, Pavlick A, Berman R, Shapiro R, Bogunovic D, O'Neill D, Yu YL, Spira J, Christos PJ, Zhou XK, Mazumdar M, Nanus DM, Liebes L, Bhardwaj N, et al. Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma. Journal of Translational Medicine. 5: 2. PMID 17207277 DOI: 10.1186/1479-5876-5-2  0.645
2007 Adams S, O'Neill D, Nonaka D, Manches O, Chiriboga L, Siu K, Shao Y, Gnjatic S, Pavlick A, Bhardwaj N. Imiquimod: A TLR-7 agonist as adjuvant for a recombinant protein cancer vaccine Journal of Clinical Oncology. 25: 8545-8545. DOI: 10.1200/Jco.2007.25.18_Suppl.8545  0.537
2006 Skoberne M, Somersan S, Almodovar W, Truong T, Petrova K, Henson PM, Bhardwaj N. The apoptotic-cell receptor CR3, but not alphavbeta5, is a regulator of human dendritic-cell immunostimulatory function. Blood. 108: 947-55. PMID 16614246 DOI: 10.1182/Blood-2005-12-4812  0.413
2006 Kavanagh DG, Kaufmann DE, Sunderji S, Frahm N, Le Gall S, Boczkowski D, Rosenberg ES, Stone DR, Johnston MN, Wagner BS, Zaman MT, Brander C, Gilboa E, Walker BD, Bhardwaj N. Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef. Blood. 107: 1963-9. PMID 16249391 DOI: 10.1182/Blood-2005-04-1513  0.454
2006 Lendvai N, Gnjatic S, Ritter E, Chen Y, Coughlin C, Vonderheide RH, Niesvizky R, Bhardwaj N, Chen-Kiang S, Old LJ, Cho HJ. Host Immune Responses Against CT Antigens in Multiple Myeloma Patients. Blood. 108: 3492-3492. DOI: 10.1182/Blood.V108.11.3492.3492  0.398
2006 Cho HJ, Ely S, Austin WR, Niesvizky R, Pearse R, Coleman M, Bhardwaj N, DiLiberto M, Chen-Kiang S, Old LJ, Jungbluth AA. Differential Expression of Type I MAGE in New and Relapsed Multiple Myeloma: Evidence for Association with Proliferation and Progression of Disease. Blood. 108: 3397-3397. DOI: 10.1182/Blood.V108.11.3397.3397  0.375
2005 O'Neill DW, Bhardwaj N. Differentiation of peripheral blood monocytes into dendritic cells. Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. Unit 22F.4. PMID 18432951 DOI: 10.1002/0471142735.Im22F04S67  0.494
2005 Beignon AS, McKenna K, Skoberne M, Manches O, DaSilva I, Kavanagh DG, Larsson M, Gorelick RJ, Lifson JD, Bhardwaj N. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. The Journal of Clinical Investigation. 115: 3265-75. PMID 16224540 DOI: 10.1172/Jci26032  0.374
2005 Demaria S, Bhardwaj N, McBride WH, Formenti SC. Combining radiotherapy and immunotherapy: a revived partnership. International Journal of Radiation Oncology, Biology, Physics. 63: 655-66. PMID 16199306 DOI: 10.1016/J.Ijrobp.2005.06.032  0.419
2005 Adams S, O'Neill DW, Bhardwaj N. Recent advances in dendritic cell biology. Journal of Clinical Immunology. 25: 177-88. PMID 16118915 DOI: 10.1007/S10875-005-4086-2  0.433
2005 Adams S, O'Neill DW, Bhardwaj N. Recent advances in dendritic cell biology. Journal of Clinical Immunology. 25: 87-98. PMID 15821885 DOI: 10.1007/S10875-005-2814-2  0.433
2005 Skoberne M, Beignon A, Larsson M, Bhardwaj N. Apoptotic cells at the crossroads of tolerance and immunity. Current Topics in Microbiology and Immunology. 289: 259-292. PMID 15791960 DOI: 10.1007/3-540-27320-4_12  0.443
2005 Leslie A, Kavanagh D, Honeyborne I, Pfafferott K, Edwards C, Pillay T, Hilton L, Thobakgale C, Ramduth D, Draenert R, Le Gall S, Luzzi G, Edwards A, Brander C, Sewell AK, ... ... Bhardwaj N, et al. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. The Journal of Experimental Medicine. 201: 891-902. PMID 15781581 DOI: 10.1084/Jem.20041455  0.361
2005 Jungbluth AA, Ely S, DiLiberto M, Niesvizky R, Williamson B, Frosina D, Chen YT, Bhardwaj N, Chen-Kiang S, Old LJ, Cho HJ. The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation. Blood. 106: 167-74. PMID 15761016 DOI: 10.1182/Blood-2004-12-4931  0.353
2005 McKenna K, Beignon AS, Bhardwaj N. Plasmacytoid dendritic cells: linking innate and adaptive immunity. Journal of Virology. 79: 17-27. PMID 15596797 DOI: 10.1128/Jvi.79.1.17-27.2005  0.425
2005 O'Neill D, Bhardwaj N. Generation of autologous peptide- and protein-pulsed dendritic cells for patient-specific immunotherapy. Methods in Molecular Medicine. 109: 97-112. PMID 15585916 DOI: 10.1385/1-59259-862-5:097  0.502
2005 O'Neill D, Bhardwaj N. Exploiting dendritic cells for active immunotherapy of cancer and chronic infection. Methods in Molecular Medicine. 109: 1-18. PMID 15585909  0.406
2005 Adams S, Lowes M, Pavlick A, Schachterle S, O’Neill D, Bhardwaj N. Spontaneous immune responses to melanoma-associated antigens in melanoma, vitiligo and healthy controls Journal of Clinical Oncology. 23: 9682-9682. DOI: 10.1200/Jco.2005.23.16_Suppl.9682  0.425
2005 Cho HJ, Farol L, Truong JT, Austin WR, Chen Y, Bhardwaj N, Niesvizky R, Old LJ, Chen-Kiang S. CT7 (MAGE-C1)-Specific Cellular Immune Responses in the Bone Marrow Microenvironment of Multiple Myeloma Patients. Blood. 106: 356-356. DOI: 10.1182/Blood.V106.11.356.356  0.389
2005 Bhardwaj N. Dendritic cell chic Springer Seminars in Immunopathology. 26: 215-219. DOI: 10.1007/S00281-004-0179-X  0.456
2004 Timm J, Lauer GM, Kavanagh DG, Sheridan I, Kim AY, Lucas M, Pillay T, Ouchi K, Reyor LL, Schulze zur Wiesch J, Gandhi RT, Chung RT, Bhardwaj N, Klenerman P, Walker BD, et al. CD8 epitope escape and reversion in acute HCV infection. The Journal of Experimental Medicine. 200: 1593-604. PMID 15611288 DOI: 10.1084/Jem.20041006  0.306
2004 Adams S, O'Neill D, Bhardwaj N. Maturation matters: importance of maturation for antitumor immunity of dendritic cell vaccines. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 3834-5; author reply. PMID 15365084 DOI: 10.1200/Jco.2004.99.019  0.465
2004 O'Neill DW, Adams S, Bhardwaj N. Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood. 104: 2235-46. PMID 15231572 DOI: 10.1182/Blood-2003-12-4392  0.478
2004 Skoberne M, Beignon AS, Bhardwaj N. Danger signals: a time and space continuum. Trends in Molecular Medicine. 10: 251-7. PMID 15177188 DOI: 10.1016/J.Molmed.2004.04.001  0.401
2004 Larsson M, Babcock E, Grakoui A, Shoukry N, Lauer G, Rice C, Walker C, Bhardwaj N. Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virus. Journal of Virology. 78: 6151-61. PMID 15163708 DOI: 10.1128/Jvi.78.12.6151-6161.2004  0.392
2004 Larsson M, Beignon AS, Bhardwaj N. DC-virus interplay: a double edged sword. Seminars in Immunology. 16: 147-61. PMID 15130499 DOI: 10.1016/J.Smim.2004.02.002  0.435
2004 Fonteneau JF, Larsson M, Beignon AS, McKenna K, Dasilva I, Amara A, Liu YJ, Lifson JD, Littman DR, Bhardwaj N. Human Immunodeficiency Virus Type 1 Activates Plasmacytoid Dendritic Cells and Concomitantly Induces the Bystander Maturation of Myeloid Dendritic Cells Journal of Virology. 78: 5223-5232. PMID 15113904 DOI: 10.1128/Jvi.78.10.5223-5232.2004  0.419
2004 Cho HJ, Jungbluth AA, Williamson B, Kolb D, Ely S, Cheng Y, Bhardwaj N, Coleman M, Niesvizky R, Old L. CT7 (MAGE-C1) is a widely expressed Cancer-Testis antigen in multiple myeloma Journal of Clinical Oncology. 22: 6554-6554. DOI: 10.1200/Jco.2004.22.90140.6554  0.327
2004 Brockstedt DG, Skoberne M, Yewdall A, Bahjat KS, Corash L, Dubensky TW, Bhardwaj N. Killed but Metabolically Active Recombinant Listeria monocytogenes as an Antigen Delivery and Activation Platform for Human Dendritic Cell-Based Cancer Immunotherapy. Blood. 104: 3447-3447. DOI: 10.1182/Blood.V104.11.3447.3447  0.834
2004 Bhardwaj N, Larsson M. Dead-cell-associated proteins are an important source of antigens for cross-presentation by dendritic cells Nature Reviews Immunology. 4: 656-656. DOI: 10.1038/Nri1308-C1  0.386
2003 Walsh SR, Bhardwaj N, Gandhil RT. Dendritic cells and the promise of therapeutic vaccines for human immunodeficiency virus (HIV)-1. Current Hiv Research. 1: 205-16. PMID 15043203 DOI: 10.2174/1570162033485285  0.524
2003 Beignon AS, Skoberne M, Bhardwaj N. Type I interferons promote cross-priming: more functions for old cytokines. Nature Immunology. 4: 939-41. PMID 14515123 DOI: 10.1038/Ni1003-939  0.425
2003 Cho HJ, Bhardwaj N. Against the self: Dendritic cells versus cancer Apmis. 111: 805-817. PMID 12974782 DOI: 10.1034/J.1600-0463.2003.11107812.X  0.488
2003 Fonteneau JF, Kavanagh DG, Lirvall M, Sanders C, Cover TL, Bhardwaj N, Larsson M. Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells. Blood. 102: 4448-55. PMID 12933572 DOI: 10.1182/Blood-2003-06-1801  0.441
2003 Larsson M, Fonteneau JF, Bhardwaj N. Cross-presentation of cell-associated antigens by dendritic cells Current Topics in Microbiology and Immunology. 276: 261-275. PMID 12797452 DOI: 10.1007/978-3-662-06508-2_12  0.432
2003 Sandberg JK, Bhardwaj N, Nixon DF. Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Vα24 NKT cell compartment European Journal of Immunology. 33: 588-596. PMID 12616479 DOI: 10.1002/Eji.200323707  0.4
2003 Bhardwaj N, Walker BD. Immunotherapy for AIDS virus infections: Cautious optimism for cell-based vaccine Nature Medicine. 9: 13-14. PMID 12514710 DOI: 10.1038/Nm0103-13  0.439
2003 Fonteneau JF, Gilliet M, Larsson M, Dasilva I, Münz C, Liu YJ, Bhardwaj N. Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood. 101: 3520-6. PMID 12511409 DOI: 10.1182/Blood-2002-10-3063  0.455
2003 Bhardwaj N. The modulation of immunity by dendritic cells Clinical and Applied Immunology Reviews. 3: 173-182. DOI: 10.1016/S1529-1049(02)00159-9  0.523
2002 Lee AW, Truong T, Bickham K, Fonteneau JF, Larsson M, Da Silva I, Somersan S, Thomas EK, Bhardwaj N. A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy. Vaccine. 20: A8-A22. PMID 12477423 DOI: 10.1016/S0264-410X(02)00382-1  0.467
2002 Kavanagh DG, Bhardwaj N. A division of labor: DC subsets and HIV receptor diversity Nature Immunology. 3: 891-893. PMID 12352961 DOI: 10.1038/Ni1002-891  0.32
2002 Shacklett BL, Means RE, Larsson M, Wilkens DT, Beadle TJ, Merritt MJ, Bhardwaj N, Palumbo PE, Skurnick JH, Louria DB, Nixon DF. Dendritic cell amplification of HIV type 1-specific CD8+ T cell responses in exposed, seronegative heterosexual women. Aids Research and Human Retroviruses. 18: 805-15. PMID 12167272 DOI: 10.1089/08892220260139558  0.423
2002 Larsson M, Fonteneau J, Lirvall M, Haslett P, Lifson JD, Bhardwaj N. Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: roles for cross-presentation and non-infectious HIV-1 virus. Aids. 16: 1319-1329. PMID 12131208 DOI: 10.1097/00002030-200207050-00003  0.445
2002 Sandberg JK, Fast NM, Palacios EH, Fennelly G, Dobroszycki J, Palumbo P, Wiznia A, Grant RM, Bhardwaj N, Rosenberg MG, Nixon DF. Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection. Journal of Virology. 76: 7528-34. PMID 12097565 DOI: 10.1128/Jvi.76.15.7528-7534.2002  0.418
2002 Fonteneau JF, Larsson M, Bhardwaj N. Interactions between dead cells and dendritic cells in the induction of antiviral CTL responses. Current Opinion in Immunology. 14: 471-477. PMID 12088682 DOI: 10.1016/S0952-7915(02)00358-8  0.47
2002 Larsson M, Wilkens DT, Fonteneau JF, Beadle TJ, Merritt MJ, Kost RG, Haslett PA, Cu-Uvin S, Bhardwaj N, Nixon DF, Shacklett BL. Amplification of low-frequency antiviral CD8 T cell responses using autologous dendritic cells. Aids (London, England). 16: 171-80. PMID 11807300 DOI: 10.1097/00002030-200201250-00005  0.464
2002 Ortiz GM, Hu J, Goldwitz JA, Chandwani R, Larsson M, Bhardwaj N, Bonhoeffer S, Ramratnam B, Zhang L, Markowitz MM, Nixon DF. Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8+ T-cell responses in subjects treated early after infection Journal of Virology. 76: 411-415. PMID 11739706 DOI: 10.1128/Jvi.76.1.411-415.2002  0.383
2002 Larsson M, Fonteneau J-, Somersan S, Sanders C, Bickham K, Thomas EK, Mahnke K, Bhardwaj N. Correction Efficiency of cross presentation of vaccinia virus‐derived antigens by human dendritic cells European Journal of Immunology. 32: 307-307. DOI: 10.1002/1521-4141(200201)32:1<307::Aid-Immu307>3.0.Co;2-T  0.378
2001 Larsson M, Fonteneau JF, Somersan S, Sanders C, Bickham K, Thomas EK, Mahnke K, Bhardwaj N. Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells. European Journal of Immunology. 31: 3432-42. PMID 11745362 DOI: 10.1002/1521-4141(200112)31:12<3432::Aid-Immu3432>3.0.Co;2-R  0.477
2001 Fonteneau J, Larsson M, Somersan S, Sanders C, Münz C, Kwok WW, Bhardwaj N, Jotereau F. Generation of high quantities of viral and tumor-specific human CD4+ and CD8+ T-cell clones using peptide pulsed mature dendritic cells. Journal of Immunological Methods. 258: 111-126. PMID 11684128 DOI: 10.1016/S0022-1759(01)00477-X  0.484
2001 Somersan S, Larsson M, Fonteneau JF, Basu S, Srivastava P, Bhardwaj N. Primary Tumor Tissue Lysates Are Enriched in Heat Shock Proteins and Induce the Maturation of Human Dendritic Cells Journal of Immunology. 167: 4844-4852. PMID 11673488 DOI: 10.4049/Jimmunol.167.9.4844  0.418
2001 Fonteneau JF, Larsson M, Bhardwaj N. Dendritic cell-dead cell interactions: Implications and relevance for immunotherapy Journal of Immunotherapy. 24: 294-304. PMID 11565831 DOI: 10.1097/00002371-200107000-00005  0.495
2001 Bhardwaj N. Processing and presentation of antigens by dendritic cells: Implications for vaccines Trends in Molecular Medicine. 7: 388-394. PMID 11530333 DOI: 10.1016/S1471-4914(01)02101-3  0.549
2001 Larsson M, Fonteneau JF, Bhardwaj N. Dendritic cells resurrect antigens from dead cells. Trends in Immunology. 22: 141-148. PMID 11286729 DOI: 10.1016/S1471-4906(01)01860-9  0.486
2001 Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. The Journal of Experimental Medicine. 193: 233-8. PMID 11208863 DOI: 10.1084/Jem.193.2.233  0.525
2001 Engelmayer J, Larsson M, Lee A, Lee M, Cox WI, Steinman RM, Bhardwaj N. Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals. Journal of Virology. 75: 2142-53. PMID 11160718 DOI: 10.1128/Jvi.75.5.2142-2153.2001  0.462
2001 Bickham K, Münz C, Tsang ML, Larsson M, Fonteneau J, Bhardwaj N, Steinman R. EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function Journal of Clinical Investigation. 107: 121-130. PMID 11134187 DOI: 10.1172/Jci10209  0.44
2000 Dhodapkar MV, Bhardwaj N. Active immunization of humans with dendritic cells Journal of Clinical Immunology. 20: 167-174. PMID 10941824 DOI: 10.1023/A:1006681312249  0.516
2000 Larsson M, Messmer D, Somersan S, Fonteneau JF, Donahoe SM, Lee M, Dunbar PR, Cerundolo V, Julkunen I, Nixon DF, Bhardwaj N. Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 165: 1182-90. PMID 10903715 DOI: 10.4049/Jimmunol.165.3.1182  0.485
2000 Dhodapkar MV, Krasovsky J, Steinman RM, Bhardwaj N. Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopes. The Journal of Clinical Investigation. 105: R9-R14. PMID 10727452 DOI: 10.1172/Jci9051  0.504
2000 Sauter B, Albert ML, Francisco L, Larsson MH, Somersan S, Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. Journal of Experimental Medicine. 191: 423-434. PMID 10662788 DOI: 10.1084/Jem.191.3.423  0.495
2000 Jin X, Roberts CGP, Nixon DF, Safrit JT, Zhang LQ, Huang YX, Bhardwaj N, Jesdale B, DeGroot AS, Koup RA. Identification of Subdominant Cytotoxic T Lymphocyte Epitopes Encoded by Autologous HIV Type 1 Sequences, Using Dendritic Cell Stimulation and Computer-Driven Algorithm Aids Research and Human Retroviruses. 16: 67-76. PMID 10628818 DOI: 10.1089/088922200309610  0.375
1999 Subklewe M, Chahroudi A, Bickham K, Larsson M, Kurilla MG, Bhardwaj N, Steinman RM. Presentation of epstein-barr virus latency antigens to CD8(+), interferon-gamma-secreting, T lymphocytes. European Journal of Immunology. 29: 3995-4001. PMID 10602009 DOI: 10.1002/(Sici)1521-4141(199912)29:12<3995::Aid-Immu3995>3.0.Co;2-E  0.468
1999 Subklewe M, Chahroudi A, Schmaljohn A, Kurilla MG, Bhardwaj N, Steinman RM. Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus. Blood. 94: 1372-81. PMID 10438725 DOI: 10.1182/Blood.V94.4.1372.416K31_1372_1381  0.414
1999 Dhodapkar MV, Steinman RM, Sapp M, Desai H, Fossella C, Krasovsky J, Donahoe SM, Dunbar PR, Cerundolo V, Nixon DF, Bhardwaj N. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. The Journal of Clinical Investigation. 104: 173-80. PMID 10411546 DOI: 10.1172/Jci6909  0.504
1999 Spiegel HML, DeFalcon E, Ogg GS, Larsson M, Beadle TJ, Tao P, McMichael AJ, Bhardwaj N, O'Callaghan C, Cox WI, Krasinski K, Pollack H, Borkowsky W, Nixon DF. Changes in Frequency of HIV-1—Specific Cytotoxic T Cell Precursors and Circulating Effectors after Combination Antiretroviral Therapy in Children The Journal of Infectious Diseases. 180: 359-368. PMID 10395850 DOI: 10.1086/314867  0.336
1999 Larsson M, Jin X, Ramratnam B, Ogg GS, Engelmayer J, Demoitie MA, McMichael AJ, Cox WI, Steinman RM, Nixon D, Bhardwaj N. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. Aids (London, England). 13: 767-77. PMID 10357375 DOI: 10.1097/00002030-199905070-00005  0.445
1999 Sapp M, Engelmayer J, Larsson M, Granelli-Piperno A, Steinman R, Bhardwaj N. Dendritic cells generated from blood monocytes of HIV-1 patients are not infected and act as competent antigen presenting cells eliciting potent T-cell responses. Immunology Letters. 66: 121-8. PMID 10203044 DOI: 10.1016/S0165-2478(98)00169-2  0.472
1999 Albert ML, Bhardwaj N, Steinman RM, Turley S, Garrett W, Mellman I, Inaba K. Uptake and presentation of phagocytosed antigens by dendritic cells Advances in Cellular and Molecular Biology of Membranes and Organelles. 5: 363-378. DOI: 10.1016/S1874-5172(99)80040-6  0.467
1998 Inaba K, Turley S, Yamaide F, Iyoda T, Mahnke K, Inaba M, Pack M, Subklewe M, Sauter B, Sheff D, Albert M, Bhardwaj N, Mellman I, Steinman RM. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. The Journal of Experimental Medicine. 188: 2163-73. PMID 9841929 DOI: 10.1084/Jem.188.11.2163  0.412
1998 Frankel SS, Steinman RM, Michael NL, Kim SR, Bhardwaj N, Pope M, Louder MK, Ehrenberg PK, Parren PW, Burton DR, Katinger H, VanCott TC, Robb ML, Birx DL, Mascola JR. Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells. Journal of Virology. 72: 9788-94. PMID 9811714 DOI: 10.1128/Jvi.72.12.9788-9794.1998  0.442
1998 Albert ML, Darnell JC, Bender A, Francisco LM, Bhardwaj N, Darnell RB. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nature Medicine. 4: 1321-4. PMID 9809559 DOI: 10.1038/3315  0.482
1998 Albert ML, Pearce SFA, Francisco LM, Sauter B, Roy P, Silverstein RL, Bhardwaj N. Immature dendritic cells phagocytose apoptotic cells via αvβ 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes Journal of Experimental Medicine. 188: 1359-1368. PMID 9763615 DOI: 10.1084/Jem.188.7.1359  0.382
1998 Bender A, Albert M, Reddy A, Feldman M, Sauter B, Kaplan G, Hellman W, Bhardwaj N. The Distinctive Features of Influenza Virus Infection of Dendritic Cells Immunobiology. 198: 552-567. PMID 9561373 DOI: 10.1016/S0171-2985(98)80078-8  0.38
1998 Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs Nature. 392: 86-89. PMID 9510252 DOI: 10.1038/32183  0.437
1997 O'Doherty U, Ignatius R, Bhardwaj N, Pope M. Generation of monocyte-derived dendritic cells from precursors in rhesus macaque blood Journal of Immunological Methods. 207: 185-194. PMID 9368645 DOI: 10.1016/S0022-1759(97)00119-1  0.449
1997 Bhardwaj N. Interactions of viruses with dendritic cells: A double-edged sword Journal of Experimental Medicine. 186: 795-799. PMID 9333647 DOI: 10.1084/Jem.186.6.795  0.399
1997 Bender A, Sapp M, Feldman M, Reddy A, Seder R, Schuler G, Steinman RM, Bhardwaj N. Dendritic cells as immunogens for human CTL responses. Advances in Experimental Medicine and Biology. 417: 383-7. PMID 9286390 DOI: 10.1007/978-1-4757-9966-8_62  0.432
1997 Reddy A, Sapp M, Feldman M, Subklewe M, Bhardwaj N. A Monocyte Conditioned Medium Is More Effective Than Defined Cytokines in Mediating the Terminal Maturation of Human Dendritic Cells Blood. 90: 3640-3646. DOI: 10.1182/Blood.V90.9.3640  0.432
1996 Granelli-Piperno A, Moser B, Pope M, Chen D, Wei Y, Isdell F, O'Doherty U, Paxton W, Koup R, Mojsov S, Bhardwaj N, Clark-Lewis I, Baggiolini M, Steinman RM. Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. The Journal of Experimental Medicine. 184: 2433-8. PMID 8976200 DOI: 10.1084/Jem.184.6.2433  0.406
1996 Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. Journal of Immunological Methods. 196: 121-35. PMID 8841451 DOI: 10.1016/0022-1759(96)00079-8  0.407
1996 Bhardwaj N, Seder RA, Reddy A, Feldman MV. IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro. Journal of Clinical Investigation. 98: 715-722. PMID 8698863 DOI: 10.1172/Jci118843  0.42
1995 Bhardwaj N, Bender A, Gonzalez N, Bui LK, Garrett MC, Steinman RM. Stimulation of human anti-viral CD8+ cytolytic T lymphocytes by dendritic cells. Advances in Experimental Medicine and Biology. 378: 375-9. PMID 8526097 DOI: 10.1007/978-1-4615-1971-3_84  0.485
1995 Bender A, Bui LK, Feldman MA, Larsson M, Bhardwaj N. Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. The Journal of Experimental Medicine. 182: 1663-71. PMID 7500011 DOI: 10.1084/Jem.182.6.1663  0.434
1994 Bhardwaj N, Bender A, Gonzalez N, Bui LK, Garrett MC, Steinman RM. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. The Journal of Clinical Investigation. 94: 797-807. PMID 8040335 DOI: 10.1172/Jci117399  0.461
1994 Bhardwaj N, Hodtsev AS, Nisanian A, Kabak S, Friedman SM, Cole BC, Posnett DN. Human T-cell responses to Mycoplasma arthritidis-derived superantigen. Infection and Immunity. 62: 135-144. DOI: 10.1128/Iai.62.1.135-144.1994  0.349
1993 Posnett DN, Hodtsev AS, Kabak S, Friedman SM, Cole BC, Bhardwaj N. Interaction of Mycoplasma arthritidis superantigen with human T cells. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. S170-5. PMID 8399910 DOI: 10.1093/Clinids/17.Supplement_1.S170  0.306
1993 Bhardwaj N, Young JW, Nisanian AJ, Baggers J, Steinman RM. Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses. The Journal of Experimental Medicine. 178: 633-42. PMID 8340760 DOI: 10.1084/Jem.178.2.633  0.462
1993 O'Doherty U, Steinman RM, Peng M, Cameron PU, Gezelter S, Kopeloff I, Swiggard WJ, Pope M, Bhardwaj N. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. The Journal of Experimental Medicine. 178: 1067-76. PMID 8102389 DOI: 10.1084/Jem.178.3.1067  0.43
1993 Pancholi P, Mirza A, Bhardwaj N, Steinman RM. Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages. Science (New York, N.Y.). 260: 984-6. PMID 8098550 DOI: 10.1126/Science.8098550  0.425
1993 Pancholi P, Mirza A, Schauf V, Steinman RM, Bhardwaj N. Presentation of mycobacterial antigens by human dendritic cells: lack of transfer from infected macrophages. Infection and Immunity. 61: 5326-32. PMID 7693599 DOI: 10.1128/Iai.61.12.5326-5332.1993  0.459
1992 Bhardwaj N, Friedman SM, Cole BC, Nisanian AJ. Dendritic cells are potent antigen-presenting cells for microbial superantigens. The Journal of Experimental Medicine. 175: 267-73. PMID 1730919 DOI: 10.1084/Jem.175.1.267  0.447
1991 Pancholi P, Steinman RM, Bhardwaj N. An approach to isolating T cell lines that react to antigens presented on the surface of dendritic cells Clinical and Experimental Immunology. 85: 349-356. PMID 1713815 DOI: 10.1111/J.1365-2249.1991.Tb05731.X  0.444
1990 Freudenthal PS, Bhardwaj N. Dendritic cells in human blood and synovial exudates International Reviews of Immunology. 6: 103-116. PMID 2152497 DOI: 10.3109/08830189009056622  0.433
1989 Steinman RM, Koide S, Witmer M, Crowley M, Bhardwaj N, Freudenthal P, Young J, Inaba K. The sensitization phase of T-cell-mediated immunity. Annals of the New York Academy of Sciences. 546: 80-90. PMID 3073702 DOI: 10.1111/J.1749-6632.1988.Tb21622.X  0.486
1989 Bhardwaj N, Lau LL, Friedman SM, Crow MK, Steinman RM. Interleukin 1 production during accessory cell-dependent mitogenesis of T lymphocytes. The Journal of Experimental Medicine. 169: 1121-36. PMID 2522495 DOI: 10.1084/Jem.169.3.1121  0.391
1988 Bhardwaj N, Lau LL, Rivelis M, Steinman RM. Interleukin-1 production by mononuclear cells from rheumatoid synovial effusions. Cellular Immunology. 114: 405-23. PMID 3260544 DOI: 10.1016/0008-8749(88)90332-2  0.345
1981 Brummer E, Bhardwaj N, Lawrence HS. A method for eliciting indurated DTH reactions to soluble protein antigens in the flank skin of mice: Correlation of visual measurements with 125I-UdR uptake indices International Archives of Allergy and Applied Immunology. 64: 266-276. PMID 7216506 DOI: 10.1159/000232703  0.329
Show low-probability matches.